AU2008212072B2 - Regulatory element from a sugarcane proline rich protein and uses thereof - Google Patents
Regulatory element from a sugarcane proline rich protein and uses thereof Download PDFInfo
- Publication number
- AU2008212072B2 AU2008212072B2 AU2008212072A AU2008212072A AU2008212072B2 AU 2008212072 B2 AU2008212072 B2 AU 2008212072B2 AU 2008212072 A AU2008212072 A AU 2008212072A AU 2008212072 A AU2008212072 A AU 2008212072A AU 2008212072 B2 AU2008212072 B2 AU 2008212072B2
- Authority
- AU
- Australia
- Prior art keywords
- sugarcane
- protein
- transgenic
- juice
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 240000000111 Saccharum officinarum Species 0.000 title claims abstract description 151
- 235000007201 Saccharum officinarum Nutrition 0.000 title claims abstract description 138
- 101710136733 Proline-rich protein Proteins 0.000 title description 17
- 102100037084 C4b-binding protein alpha chain Human genes 0.000 title description 16
- 230000001105 regulatory effect Effects 0.000 title description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 194
- 241000196324 Embryophyta Species 0.000 claims abstract description 114
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 48
- 238000003306 harvesting Methods 0.000 claims abstract description 3
- 230000009261 transgenic effect Effects 0.000 claims description 68
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
- 239000012528 membrane Substances 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 7
- 230000002101 lytic effect Effects 0.000 claims description 7
- 230000000840 anti-viral effect Effects 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 230000000749 insecticidal effect Effects 0.000 claims description 5
- 108090001090 Lectins Proteins 0.000 claims description 4
- 102000004856 Lectins Human genes 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000002523 lectin Substances 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 229960005486 vaccine Drugs 0.000 claims description 2
- 239000013618 particulate matter Substances 0.000 claims 3
- 238000007670 refining Methods 0.000 claims 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 1
- 230000009466 transformation Effects 0.000 abstract description 30
- 241000209510 Liliopsida Species 0.000 abstract description 18
- 238000000746 purification Methods 0.000 abstract description 13
- 230000008929 regeneration Effects 0.000 abstract description 10
- 238000011069 regeneration method Methods 0.000 abstract description 10
- 230000002068 genetic effect Effects 0.000 abstract description 9
- 239000002299 complementary DNA Substances 0.000 description 99
- 108020004414 DNA Proteins 0.000 description 77
- 235000018102 proteins Nutrition 0.000 description 66
- 230000014509 gene expression Effects 0.000 description 55
- 210000004027 cell Anatomy 0.000 description 48
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 32
- 108091026890 Coding region Proteins 0.000 description 29
- 240000008042 Zea mays Species 0.000 description 25
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 25
- 235000009973 maize Nutrition 0.000 description 25
- 238000012216 screening Methods 0.000 description 23
- 230000014616 translation Effects 0.000 description 22
- 244000062793 Sorghum vulgare Species 0.000 description 21
- 239000002773 nucleotide Substances 0.000 description 21
- 125000003729 nucleotide group Chemical group 0.000 description 21
- 238000012163 sequencing technique Methods 0.000 description 21
- 238000013519 translation Methods 0.000 description 21
- 108090000848 Ubiquitin Proteins 0.000 description 20
- 239000012634 fragment Substances 0.000 description 20
- 108020004999 messenger RNA Proteins 0.000 description 20
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 239000013598 vector Substances 0.000 description 18
- 102000044159 Ubiquitin Human genes 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 238000012545 processing Methods 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 238000009396 hybridization Methods 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 238000002105 Southern blotting Methods 0.000 description 14
- 241000700605 Viruses Species 0.000 description 14
- 150000001413 amino acids Chemical group 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000010276 construction Methods 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- 102000039446 nucleic acids Human genes 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 13
- 108091092195 Intron Proteins 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 108091008146 restriction endonucleases Proteins 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 108020004635 Complementary DNA Proteins 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 108700019146 Transgenes Proteins 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 9
- 239000004009 herbicide Substances 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000009313 farming Methods 0.000 description 8
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 8
- 230000002363 herbicidal effect Effects 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 230000001404 mediated effect Effects 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 239000002028 Biomass Substances 0.000 description 7
- 101710132601 Capsid protein Proteins 0.000 description 7
- 101710094648 Coat protein Proteins 0.000 description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 7
- 101710125418 Major capsid protein Proteins 0.000 description 7
- 101710141454 Nucleoprotein Proteins 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 101710083689 Probable capsid protein Proteins 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 108700009124 Transcription Initiation Site Proteins 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 230000000853 biopesticidal effect Effects 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 239000004325 lysozyme Substances 0.000 description 7
- 229960000274 lysozyme Drugs 0.000 description 7
- 238000013507 mapping Methods 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 241000219194 Arabidopsis Species 0.000 description 6
- 108010014251 Muramidase Proteins 0.000 description 6
- 102000016943 Muramidase Human genes 0.000 description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 6
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 6
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 6
- 241000723806 Sugarcane mosaic virus Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000013599 cloning vector Substances 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 230000000408 embryogenic effect Effects 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 238000010353 genetic engineering Methods 0.000 description 6
- 235000010335 lysozyme Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000003801 milling Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 5
- 108010085238 Actins Proteins 0.000 description 5
- 108091029865 Exogenous DNA Proteins 0.000 description 5
- 244000061176 Nicotiana tabacum Species 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 241000209504 Poaceae Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 241001233957 eudicotyledons Species 0.000 description 5
- 230000030279 gene silencing Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 241000209051 Saccharum Species 0.000 description 4
- 240000005382 Saccharum spontaneum Species 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 241000723873 Tobacco mosaic virus Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 238000004166 bioassay Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 238000005352 clarification Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 238000003259 recombinant expression Methods 0.000 description 4
- 108010076805 snowdrop lectin Proteins 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- 108700013095 wheat WPRP1 Proteins 0.000 description 4
- FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- 238000007399 DNA isolation Methods 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 241000710078 Potyvirus Species 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 241001455595 Sorghum mosaic virus Species 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 108700026226 TATA Box Proteins 0.000 description 3
- 108091023045 Untranslated Region Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000012226 gene silencing method Methods 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 238000011020 pilot scale process Methods 0.000 description 3
- 108700000017 plant hybrid proline-rich Proteins 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- -1 sunlight Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- KDELTXNPUXUBMU-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid boric acid Chemical compound OB(O)O.OB(O)O.OB(O)O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KDELTXNPUXUBMU-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 235000015256 Chionanthus virginicus Nutrition 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 241000234271 Galanthus Species 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108700001094 Plant Genes Proteins 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 241000709992 Potato virus X Species 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 241000701507 Rice tungro bacilliform virus Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000826915 Saccharum officinarum complex Species 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 108010045649 agarase Proteins 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 101150087698 alpha gene Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 101150103518 bar gene Proteins 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 239000003014 ion exchange membrane Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000001823 molecular biology technique Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 125000001151 peptidyl group Chemical group 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000012882 rooting medium Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101150029062 15 gene Proteins 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- DWKNOLCXIFYNFV-HSZRJFAPSA-N 2-[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]piperidin-4-yl]-5-oxopyrrolidine-2-carbonyl]amino]-n,n,6-trimethylpyridine-4-carboxamide Chemical compound CN(C)C(=O)C1=CC(C)=NC(NC(=O)[C@@H]2N(C(=O)CC2)C2CCN(CC=3C=C(C)C(Cl)=CC=3)CC2)=C1 DWKNOLCXIFYNFV-HSZRJFAPSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 101100010926 Arabidopsis thaliana A1 gene Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- 241000701248 Chlorella virus Species 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 108091028732 Concatemer Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 241000701484 Figwort mosaic virus Species 0.000 description 1
- 241000724791 Filamentous phage Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
- 101710180399 Glycine-rich protein Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 101710133652 Lectin-like protein Proteins 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101150047731 MTDH gene Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 108700005084 Multigene Family Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101150057301 PRP gene Proteins 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 108010068086 Polyubiquitin Proteins 0.000 description 1
- 102100038788 Proline-rich protein 15 Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101000933967 Pseudomonas phage KPP25 Major capsid protein Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 108091036333 Rapid DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 101150021653 SPRP gene Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000015505 Sorghum bicolor subsp. bicolor Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- 102100028262 U6 snRNA-associated Sm-like protein LSm4 Human genes 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 101000662549 Zea mays Sucrose synthase 1 Proteins 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000008645 cold stress Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 101150095418 crop gene Proteins 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940094991 herring sperm dna Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009403 interspecific hybridization Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000010667 large scale reaction Methods 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000001320 lysogenic effect Effects 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001116 prolino group Chemical group [H]OC(=O)C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000010512 small scale reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a method of identifying genetic elements useful for genetically engineering sugarcane or other monocots, to the transformation of the monocots with the genetic elements so that they produce a desired product, to regeneration of engineered plants for harvesting, and to purification of the product, such as a high value protein, from the regenerated plants. The invention also relates to novel ways to identify promoters useful for transformation of plants and to promoters identified according to the invention.
Description
AUSTRALIA Patents Act 1990 COMPLETE SPECIFICATION Standard Patent Applicant (s) THE TEXAS A&M UNIVERSITY SYSTEM Invention Title: REGULATORY ELEMENT FROM A SUGARCANE PROLINE RICH PROTEIN AND USES THEREOF The following statement is a full description of this invention, including the best method for performing it known to me/us: P?5112.AU.2 PatSetFiling Appkcation 2008-9-9 doc (P) METHODS AND CONSTRUCTS FOR PRODUCING TRANSGENIC PLANTS AND METHODS OF RECOVERING EXPRESSED PROTEINS FIELD OF THE INVENTION 5 This invention relates to the genetic engineering and processing of transgenic sugarcane for the recovery of high value proteins, and to molecular farming with transgenic gramineous crops. 10 BACKGROUND OF THE INVENTION Sugarcane is one of the most important global crops with an estimated annual net value of $143 billion (FAO Statistics, 1996). Modern cultivated sugarcane (Saccarum spp, hybrids) belongs to the genus Saccharum, an 15 interspecific hybrid between the domesticated species Saccharum officinarum and its wild relative S. spontaneum. Chromosome numbers of sugarcane cultivars range from 100 to 130 with approximately 10% being contributed by S. spontaneum. 20 Interspecific hybridization has led to a huge improvement in sugarcane breeding. It has solved some disease problems, increased biomass yield and sugar yield, and improved adaptability for growth under various stress conditions (Roach et al., 1972, Srivastava et al., 1994). 25 The production of transgenic plants may provide another complementary method for sugarcane breeding. There are various transformation methods that have been developed. Transformation mediated by Agrobacterium has provided a reliable means of creating transgenic plants in many 30 species. Particle bombardment (biolistics) and electroporation have proved to be another successful method with monocots, which are less susceptible to Agrobacterium than dicots. Sugarcane has reliable systems for both transient gene expression and production of 35 transgenic plants. The most commonly used method for transformation of sugarcane is particle bombardment combined with a herbicide resistance gene as a selectable - 2 marker (Gallo-Meagher and Irvine, 1993; 1996; Bower et al., 1992; 1996). Production of transgenic sugarcane plants by intact cell electroporation has also been reported (Arencibia et al., 1995). Recently, 5 Agrobacterium-mediated transfer has been used successfully in sugarcane transformation (Endquez-Obregon et al., 1998; Arencibia et al., 1998). In spite of reliable techniques for transformation, the expression level of a transgene is 10 still of concern. A DNA construct or vector that drives very high levels of expression is critical in the production of transgenic plants. In general, a transgene vector consists of a very simple construct in which the gene of interest is coupled to a promoter derived from a 15 plant, a virus or a bacterium. Some promoters confer constitutive expression (like ubiquitin and actin), while others may be tissue-specific, wound-inducible, chemically-inducible or developmentally regulated. The CaMV35S promoter is a well known constitutive 20 and active promoter in dicots, but much less so in monocots. A number of investigations have shown that promoters isolated from monocots show higher activity in monocot Species, and that dding an intron between the promoter and the reporter sene increases transcription' 25 levels (Wilmink et al., 1995; Ruthus et al., 1993; Maas et al., 1991). The rice actin promoter Act1 (McElroy et al., 1991; Wang et al., 1992; Zhang et al., 1991) and the maize ubiquitin promoter Ubi (Christensen et al., 1992) achieved far better expression than CaMV35S in most monocots 30 tested. Among promoters tested in sugarcane, the Emu promoter and the maize ubiquitin promoter showed better expression than CaMV35S promoter (McElroy et al., 1991; Gallo-Meagher et al., 1993; Rathus et al., 1993). In contrast to cereal crops, in monocots such as tulip, lily 35 and leek, the activities of the monocot promoters were much lower and did not significantly exceed the activity of the CaMV35S promoter. In dicots, the ubiquitin -3 promoter also showed weaker activity than the CaMV35S promoter (Callis et al., 1990; Mitra et al., 1994). Variation in transgene expression levels between different species and promoters may be due to transcription factors, 5 recognition of promoter sequences or intron splicing sites (Wilmink et al., 1995) or other factors. So far, no one has reported the use of promoters or introns from sugarcane itself. Endogenous sugarcane promoters may drive higher levels of expression of transgenes or more 10 stable expression compared to heterologous promoters. Promoters currently used in monocot transformation are mostly derived from highly expressed genes, such as actin or ubiquitin. The abundance of mRNA can be due to copy number of the gene (GENES V, pp. 703) 15 or to the strength of the promoter (Holtorf et al., 1995). There are no reports indicating what genes are most abundantly expressed in sugarcane, or the gene copy number 'for abundant messenger RNA in the sugarcane genome. The applicant describes herein newly identified promoters 20 isolated from sugarcane which may prove useful in the expression in monocots of genes of interest. SUMMARY OF THF INVENTION In its broadest embodiment the present invention 25 provides a method of identifying genetic elements useful for genetically engineering sugarcane or other monocots, to the transformation of the monocots with the genetic elements so that they produce a desired product, to regeneration of engineered plants for harvesting, and to 30 purification of the desired product, such as a high value protein, from the regenerated plants. The invention also relates to novel ways to identify promoters useful for transformation of plants and to promoters identified according to the invention. 35 In one of the more general aspect, the invention disclosed herein provides a nucleic acid construct which may be inserted into the genome of any target plant. The -4 construct uses as a promoter a promoter isolated from sugarcane as disclosed herein. Accordingly, in a first aspect, the present invention 5 provides a nucleic acid construct for the expression of foreign genes in a plant, comprising a nucleotide sequence as shown in FIG. 3. In a second aspect, the present invention provides a io nucleic acid molecule, which encodes a promoter having a nucleotide sequence substantially as shown in FIG. 3. In a third aspect, the present invention provides a nucleic acid molecule, which encodes a promoter having: 15 a) a nucleotide sequence as shown in FIG. 3.; or b) a biologically active fragment of the sequence in a); or c) a nucleic acid molecule which has at least 75% sequence homology to the sequence in a) or b); or 20 d) a nucleic acid molecule which is capable of hybridizing to the sequence in a) or b) under stringent conditions. In a fourth aspect, the present invention provides a 25 transgenic plant stably transformed with a construct according to the invention. Modified and variant forms of the constructs may be produced in vitro, by means of chemical or enzymatic 30 treatment, or in vivo by means of recombinant DNA technology. Such constructs may differ from those disclosed, for example, by virtue of one or more nucleotide substitutions, deletions or insertions, but substantially retain a biological activity of the 35 construct or nucleic acid molecule of this invention. 3145121_1 (GIHMatters) P751 12.AU.2 13/02/12 - 4a In a fifth aspect the invention provides a method of transforming sugarcane and regenerating said sugarcane using a reproducible biolistic-based transformation and regeneration system and the resulting plants cultured. 5 High value protein and other materials are extracted from the harvested plants. BRIEF DESCRIPTION OF THE DRAWINGS 10 Figure 1 shows a genetic map of highly-expressed sugarcane genes on the sorghum map. Figure 2 shows a genetic map of highly-expressed sugarcane genes on the sugarcane map. Figure 3 shows the nucleotide sequence and deduced 15 amino acid sequence of the cDNA insert SPRP1. Figure 4 shows the 5' nucleotide sequence of SPRP2 and the deduced amino acid sequence. Figure 5 shows the hydrophobicity plots of sugarcane proline-rich protein. 20 Figure 6 shows the 5' upstream and partial nucleotide sequence of SPRP gene. Figure 7 shows the base composition of PRP genomic DNA sequence from -1857 to 691. Figure 8 shows restriction map of SPRP1. 25 Figure 9 shows the cDNA sequence of EFla. Figure 10 shows restriction map of EF1x. Figure 11 shows the DNA sequence of sugarcane EFlac genomic clone (4537 bp). Figure 12 shows the A and T base composition plot of 30 SEFla genomic DNA sequence from -1967 to 2570. In the claims which follow and in the preceding description of the invention, except where the context requires otherwise due to express language or necessary 35 implication, the word "comprise" or variations such as "comprises" or "comprising" is used in an inclusive sense, i.e. to specify the presence of the stated features but 3145121_1 (GHMatters) P75112.AU.2 13/02/12 - 5 not to preclude the presence or addition of further features in various embodiments of the invention. It is to be understood that, if any prior art publication 5 is referred to herein, such reference does not constitute an admission that the publication forms a part of the common general knowledge in the art, in Australia or any other country. 10 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 3145121_1 (GIMatters) P75112 AU 2 13102/12 - Sa The practice of the present invention employs, unless otherwise indicated, conventional molecular biology, microbiology, and recombinant DNA techniques 5 within the skill of the art. Such techniques are well known to the skilled worker, and are explained fully in the literature. See, eg., Maniatis, Fritsch & Sambrook, "Molecular Cloning: A Laboratory Manual" (1982); "DNA Cloning: A Practical Approach," Volumes I and II (D.N. 10 Glover, Ed., 1985); "Oligonucleotide Synthesis" (M.J. Gait, Ed., 1984); "Nucleic Acid Hybridization" (B.D. Hames & S.J. Higgins, eds., 1985); "Transcription and Translation" (B.D. Hames & S.J. Higgins, eds., 1984); -6 "Animal Cell Culture" (R.I. Freshney, Ed., 1986); "Immobilized Cells and Enzymes" (IRL Press, 1986); B. Perbal, "A Practical Guide to Molecular Cloning" (1984), and Sambrook, et al., "Molecular Cloning: a Laboratory 5 Manual" 12t edition (1989). -The description that follows makes use of a number of terms used in recombinant DNA technology. In order to provide a clear and consistent understanding of the specification and claims, including the scope given 10 such terms, the following definitions are provided. A "nucleic acid molecule' or "polynucleic acid molecule" refers herein to deoxyribonucleic acid and ribonucleic acid in all their forms, ie:, single and double-stranded DNA, cDNA, mRNA, and the like. 15 A "double-stranded DNA molecule' refers to the polymeric form of deoxyribonucleotides (adenine, guanine, thymine, or cytosine) in its normal, double-stranded helix. This term refers only to the primary and secondary structure of the molecule, and does not limit it to any 20 particular tertiary forms. Thus this term includes double-stranded DNA found, inter alia, in linear DNA molecules (eg., restriction fragments), viruses, plasmids, and chromosomes. In discussing the structure of particular double-stranded DNA molecules, sequences may be 25 described herein according to the normal.convention of giving only the sequence in the 5' to 3' direction along the non-transcribed strand of DNA (ie., the strand having' a sequence homologous to the mRNA). A DNA sequence "corresponds" to an amino acid 30 sequence if translation of the DNA sequence in accordance with the genetic code yields the amino acid sequence (ie., the DNA sequence "encodes" the amino acid sequence). One DNA sequence "corresponds" to another DNA sequence if the two sequences encode the same amino acid 35 sequence. Two DNA sequences are "substantially similar' when at least about 85%, preferably at least about 90%, -7 and most preferably at least about 95%, of the nucleotides match over the defined length of the DNA sequences. Sequences that are substantially similar can be identified in a Southern hybridization experiment, for example under 5 stringent conditions as defined for that particular system. Defining appropriate hybridization conditions is within the skill of the art. See eg., Sambrook et al., DNA Cloning, vols. I, II and III. Nucleic Acid Hybridization. However, ordinarily, "stringent conditions" for 10- hybridization or annealing of nucleic acid molecules are those that (1) employ low ionic strength and high -temperature for washing, for example, 0.015M NaCl/0.0015M sodium citrate/0.1% sodium dodecyl sulfate (SDS) at 500C, or 15 (2) employ during hybridization a denaturing agent -such as formamide, for example, 50% (vol/vol) formamide with 0.1% bovine serum albumin/0.1% Ficoll/0.1% polyvinylpyrrolidone/50mM sodium phosphate buffer at pH 6.5 with 750mM NaCl, 75mM sodium citrate at 42*C. 20 Another example is use of 50% formamide, 5 X SSC (0.75M NaCl, 0.075M sodium citrate), 50mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5 X Denhardt's solution, sonicated salmon sperm DNA (50gg/mL), 0.1% SDS, and 10% dextran sulfate at 42*C, with washes at 420C in 0.2 25 X SSC and 0.1% SDS. A "heterologous" region or domain of a DNA construct is an identifiable segment of DNA within a larger DNA molecule that is not found in association with the larger molecule in nature. Thus, when the 30 heterologous region encodes a mammalian gene, the gene will usually be flanked by DNA that does not flank the mammalian genomic DNA in the genome of the source organism. Another example of a heterologous region is a construct where the coding sequence itself is not found in 35 nature (eg., a cDNA where the genomic coding sequence contains introns, or synthetic sequences having codons different than the native gene). Allelic variations or -8 naturally-occurring mutational events do not give rise to a heterologous region of DNA as defined herein. A "coding sequence" is an in-frame sequence of codons that correspond to or encode a protein or peptide 5 sequence. Two coding sequences correspond to each other if the sequences or their complementary sequences encode the same amino acid sequences. A coding sequence in association with appropriate regulatory sequences may be transcribed and translated into a polypeptide in vivo. A 10 polyadenylation signal and transcription termination sequence will usually be located 3' to the coding sequence. A "promoter sequence" is a DNA regulatory region capable of binding RNA polymerase in a cell and initiating 15 transcription of a downstream (3' direction) coding sequence. A coding sequence is "under the control' of the promoter sequence in a cell when RNA polymerase which binds the promoter sequence transcribes the coding sequence into mRNA, which is then in turn translated into 20 the protein encoded by the coding sequence. For the purposes of the present invention, the promoter sequence is bounded at its 3' terminus by the translation start codon of a coding sequence, and extends upstream to include the minimum number of bases or 25 elements necessary to initiate transcription at levels detectable above background. Within the promoter sequence will be found a transcription initiation site (conveniently defined by mapping with nuclease SI), as well as protein binding domains (consensus sequences) 30 responsible for the binding of RNA polymerase. Eukaryotic promoters will often, but not always, contain "TATA" boxes and "CAT" boxes, prokaryotic promoters contain Shine Delgarno sequences in addition to the -10 and -35 consensus sequences. 35 A cell has been "transformed" by exogenous DNA when such exogenous DNA has been introduced inside the cell wall. Exdgenous DNA may or may not be integrated -9 (covalently linked) to chromosomal DNA making up the genome of the cell. In prokaryotes and yeast, for example, the exogenous DNA may be maintained on an episomal element such as a plasmid. With respect to 5 eukaryotic cells,*a stably transformed cell is one in which the exogenous DNA is inherited by daughter cells through chromosome replication. This stability is demonstrated by the ability of the eukaryotic cell to establish cell lines or clones comprised of a population 10 of daughter cells containing the exogenous DNA. "Integration" of the DNA may be effected using non-homologous recombination following mass transfer of DNA into the cells using microinjection," biolistics, electroporation or lipofection. Alternative methods such 15 as homologous recombination, and or restriction enzyme mediated integration (REMI) or transposons are also encompassed, and may be considered to be improved integration methods. A "clone" is a population of cells derived from a 20 single cell or common ancestor by mitosis. "Cell," "host cell," "cell line," and "cell culture" are used interchangeably herewith and all such terms should be understood to include progeny. A "cell line" is a clone of a primary cell that is capable of 25 stable growth in vitro for many generations. Thus the words "transformants" and "transformed cells" include the primary subject cell and cultures derived therefrom, without regard for the number of times the cultures have been passaged. It should also be understood that all 30 progeny might not be precisely identical in DNA content, due to deliberate or inadvertent mutations. Vectors are used to introduce a foreign substance, such as DNA, RNA or protein, into an organism. Typical vectors include recombinant viruses (for DNA) and 35 liposomes (for protein). A "DNA cloning vector" is an autonomously replicating DNA molecule, such as plasmid, phage or cosmid. Typically the DNA cloning vector - 10 comprises one or a small number of restriction endonuclease recognition sites, at which such DNA .sequences may be cut in a determinable fashion without loss of an essential biological function of the vector, 5 and into which a DNA fragment may be spliced in order to bring about its replication and cloning. The cloning vector may also comprise a marker suitable for use in the identification of cells transformed with the cloning vector. 10 An "expression vector" is similar to a DNA cloning vector, but contains regulatory sequences which are able to direct protein synthesis b9 an appropriate host cell. This usually means a promoter to bind RNA polymerase and initiate transcription of mRNA, as well as 15 ribosome binding sites and initiation signals to direct translation of the mRNA into a polypeptide. Incorporation of a DNA sequence into an expression vector at the proper site and in correct reading frame, followed by transformation of an appropriate host cell by the vector, 20 enables the production of mRNA corresponding to the DNA sequence, and usually of a protein encoded by the DNA sequence. As embodied and broadly described herein, the present invention is directed to processing of transgenic 25 sugarcane for the recovery of high value proteins. The invention also relates to identification and utilisation of promoters useful in genetically engineering sugarcane plants, the use of sugarcane as an expression system, and to methods of genetic engineering and 30 manufacturing of products, such as' high value proteins, from transformed sugarcane. The invention also includes products, such as proteins, produced according to the invention. The invention further includes equipment for the genetic engineering and manufacturing of products, 35 such as high value proteins, from the transformed sugarcane. The invention is not limited to sugarcane, but may be applied to other plants, such as sorghum.
- 11 Crop plants improved by the insertion of foreign genes constitutes one of the main goals of plant genetic engineering. The transgenic plant technologies developed in our laboratories are useful for development and 5 commercialisation of molecular farming in transgenic grasses. Plants can be viewed as small efficient factories that need only water, sunlight, minerals, and the right combination of additional genes to economically produce 10 exactly what industry wants. Given the right genes, plants can be used as recombinant expression systems to produce large quantities of modified starches, valuable industrial oils, plastics, Pharmaceuticals, vaccines or enzymes for food processing and other industries. 15 Because of high biomass potential, multi functional utility, existing processing plants and other features, sugarcane was identified as an ideal recombinant expression system. Transgenic sugarcane has been demonstrated to be an ideal system for continued 20 development towards commercialisation of molecular farming. Sorghum is also a useful system. In addition to the fact that sugarcane produces more biomass per acre than any other annual crop, the following unique features make sugarcane a particularly useful recombinant 25' expression system.- 1) The per weight'basis of protein in the extracted sugarcane juice is 0.2% and the remainder is mostly sucrose and water. The sucrose provides stabilisation of the heterologous protein. 2) Since the overall protein content is low, the starting material for 30 purifying the recombinant protein is a simple mixture which will facilitate the purification process. The heterologous genes we expressed in sugarcane produce bactericidal lytic peptides 'and proteins and insecticidal and antiviral lectins that have high value as 35 antimicrobial pharmaceuticals or biopesticides. The large biomass produced by these crops, and the milling technology in place for sugarcane offered a unique - 12 situation to capture transgenically expressed proteins as value added products. Transgenic peptides and proteins would be expected in the normally discarded residue of the first processing step after milling, juice clarification. 5 The large scale extraction and purification of these value added products from the normally discarded residue generated in the first step of the sugarcane milling process, and commercialisation of this technology will provide new worldwide markets for sugarcane producers. 10 Furthermore, by combining the strengths of classical crop improvement and plant biotechnology in our laboratories, the invention provides avenues for crop gene manipulation for crop improvement. The transformation and extraction technology of the invention may be applied to a broad 15 range of proteins and other plants, such as sorghum. There are two main bottlenecks for improving crop plants by gene transfer. First, many useful genes have not been precisely identified. The second major bottleneck concerns the inability-to regenerate plants from the cells 20 into which the new genes have been transferred. These constraints have been overcome according to the invention. The invention provides a reproducible biolistic based transformation and regeneration system for creating transgenic disease and herbicide resistant sugarcane. 25 Using the invention, sugarcane can be successfully transformed on a routine basis. In one example, we transgenically expressed in sugarcane the cDNA coding for the snow drop lectin, a potent broad spectrum insecticidal and antiviral protein 30 found in the bulb of the snow drop lily. This protein may have many potential uses in the biopesticide industry, but was mainly used as a proof of principal. The volume and price at which these kinds of high value proteins can be produced will determine to what 35 extent they will be available for use, Current production methods are too expensive to allow for widespread.market penetration. The current commercial cost of the snow drop - 13 lectin is $1'0,000 per gram. Based on current expression levels (-1.0%) of heterologous protein being achieved in our transgenic sugarcane plants, we expect to be able to produce these proteins for as low as $100.00 per gram 5 using sugarcane as a recombinant expression system. This production cost would allow for widespread penetration into new markets. Using standard molecular biology techniques, the gene encoding the snow drop lectin was fused between the 10 maize ubiquitin promoter (this promoter is a strong constitutive promoter in grasses) and the nopaline synthase transcriptional terminator in a high copy number plasmid. This construct was used in biclistic co transformation experiments using the maize ubiquitin/nptII 15 gene construct (resistance to the antibiotic geneticin) as the selectable marker. The initial sugarcane cultivar to be transformed was CP65-357 as it is easy to regenerate. Targets of embryogenic calli were produced by culturing immature flower inflorescence on tissue culture medium 20 supplemented with 3mg/l 2,4-D. These embryogenic calli were bombarded (using a helium driven particle inflow gun) with tungsten particles coated with the appropriate plasmid DNAs to provide 4jpg per shot. Plants were cultured on tissue culture medium supplemented with 3mg/l 2,4-D and 25 45mg/l geneticin. After 9 weeks, resistant calli were. transferred to medium supplemented with 1mg/ll 2,4-D and 45mg/l geneticin to promote shoot regeneration. Shoots were subcultured every two weeks on this medium for two months at which time they were placed on rooting medium 30 containing 45mg/l geneticin. Plants displaying well developed roots were screened for the presence and expression of the transgene by PCR, Southern and Western blot analyses. A set of the highest expressors were grown in the greenhouse, and then in the field. The 35 transgenically expressed protein was purified from these transgenic plants using tissue extraction, differential ultrafiltration, and ion exchange HPLC. Small plots of - 14 these transgenic plants were field grown for the initial pilot plant scale processing experiments conducted using the pilot plant located at the sugar mill in Santa Rosa, TX. 5 The next phase used the transgenic sugarcane plants developed in our laboratories to take the next step required for the commercialisation of molecular farming in transgenic grasses. This transformation and extraction technology could be applied to a broad range of plants and 10 high value proteins or other compounds. The large scale extraction and purification of these value added products, and the commercialisation of this technology will provide new worldwide markets for novel products produced in transgenic sugarcane or other plants. 15 The molecular farming phase requires a non destructive method for recovering high value proteins or peptides (i.e., pharmaceutical peptides) from transgenic sugarcane. In processing cane, the industry crushes the stalk to extract the juice, then washes the residue with 20 water to complete the extraction. This mixture is then adjusted to pH7.0 with lime and heated to 90*C, the flocculent is removed and the juice evaporated to syrup for crystallisation of the sucrose. We predicted that the transgenically expressed proteins of interest would be 25 removed with the flocculent. Because of the complexity of the mixture that is being heated, we cannot predict the stability of the proteins in the processing routine. New technology for juice clarification developed in beet processing and now being adapted for cane processing 30 enables the raw process material to be clarified without heating or liming. The process is micron filtration which removes high molecular weight materials from the juice and - leaves a clear filtrate that contains the high value proteins. We then use this fraction for protein 35 extraction and purification, For this, we constructed a pilot scale micron filtration unit coupled to ultramicron filtration and ion exchange chromatography units to - 15 separate the protein fraction of the juice and to prepare it for further purification. Using transgenic sugarcane expressing the snow drop lectin (an insecticidal and antiviral protein), we 5 have made six runs through the pilot plant. The transgenic sugarcane is first shredded and crushed twice (without maceration water).:in a pilot scale Squire mill. Essentially, the cane stalk is shredded and then pressed through 3 rollers on the Squire mill with 10 3,000 pounds per square inch. This produces a mixture of about 70% water, 15% sucrose, and 10% fibre. The remaining 5% of the mixture consists of proteins and other sugars,- salts and organic molecules. The juice containing the high value protein is then pumped to a purification 15 skid and filtered through a set of vibrating (self cleaning) screens and enters a tank. This step removes the fibre. The first screen is 150 microns, and the second is 100 microns. The pH of the juice is adjusted to 5.2 and it is supplemented with 1mM EDTA and 0.1% sodium 20 sulphite to prevent oxidation and the formation of phenolics. From the tank the juice is permeated through a 0.2 micron cross flow filtration membrane. This step removes all the insoluble solids and high molecular weight soluble solids such as bacteria, starches and dextrans. -25 The permeate, -which contains sugar and the high value protein, enters a second tank and the retentate in the first tank is discarded. From the second tank, the juice is permeated through a 0.05 micron membrane. This step removes soluble molecules with a molecular weigh greater 30 than 150,000kd. High value proteins with a molecular weight greater than 150,000kd would be retained in the second tank, and-could be further purified with the HPLC steps described below. The second permeate, which contains sugar and the high value proteins smaller than 35 150,000 W (snow drop lectin in this example) enters a third tank and the retentate in the second tank is discarded. At this point we have a relatively clean - 16 sample from which all high molecular weight material has been removed, i.e., bacteria, starch, dextrans, and proteins with high molecular weights. From the third tank, the sample is further 5 purified by 2 cycles of high pressure liquid chromatography (HPLC). The first cycle uses Dowex Mono 66 ion exchange resin, while the second cycle uses a hydrophobic interaction resin. Preliminary runs produced protein. 10 An additional step in the lab was added to obtain a highly pure protein. Further modifications can be made to address large volumes produced in the third tank. The first two membranes process the juice aE 2 gallons per minute, but the HPLC can only handle 300ml, per minute. 15 We have identified low molecular weight out off membranes that can be used to concentrate the sample in the third tank. The water, sugars and other small molecules will flow through the membranes, but thd high value protein will be concentrated in the third tank. This will greatly 20 improve the performance of the HPLC steps. Further modifications using different initial extraction conditions, different ion exchange resins/membranes, affinity resins and HPLC columns can be used to enhance performance. 25 The- initial pilot plant incorporated a Squire mill, piping and valves from the mill to the juice tank to the purification unit. Additional useful instrumentation which may be incorporated include pilot scale nano filtration (30,000 and 10,000 molecular weight cut-off) 30 equipment, new HPLC columns and new ion exchange resins/membranes. This will greatly improve the performance and efficiency of the HPLC stops. The processing plants according to the invention described herein, or incorporating an ultramicron filtration unit 35 coupled to a de-watering system, may be used to extract and purify transgenically expressed proteins, including such biologically active high value proteins as - 17 pharmaceutical proteins, biopesticides, and lytic peptides. The invention allows for the rapid economic production of large quantities of.high value proteins. 5 Large amounts of transgenic plant material can rapidly be processed to produce large quantities of recombinantly expressed proteins, It is envisioned that this process could be used on any type of transgenic plant material to product essentially any type of protein. Slight 10 modifications to the initial extraction maybe made for different types of starting materials,.and the size exclusion of the molecular weight cut off membranes could be altered for each specific protein, a§ could be the final HPLC steps. 15 The following additional examples are offered to illustrate embodiments of the invention, and should not be viewed as limiting the scope of the invention. EXAMPLE 1 DEVELOPMENT OF TRANSGENIC GRASSPS FOR 20 MOLECULAR FARMING This example relates to developing transgenic grasses suitable for molecular farming. Because of high biomass potential and multi-functional utility, sugarcane or sorghum may be used. The first step will be to 25 introduce genes into these crops which will economically produce high value lytic peptides and proteins to be used in the pharmaceutical and biopesticide industries. Sugarcane and sorghum, closely related plants, are very efficient producers of biomass, and the sugarcane milling 30 process is an efficient biomass extraction system. Transgenically expressed peptides and proteins would be expected in the normally discarded residue of the first processing step after milling, juice clarification. Genetic transformation of grass-like crops has 35 previously been slow because the methods of gene transfer that work for broadleaf plants are not suitable. We have developed a particle bombardment transformation system and - 18 a regeneration and screening technique which we used to produce transgenic sugarcane that is herbicide resistant. We have made significant progress in applying the technique to varieties of sorghum. 5 (For example, in connection with herbicide resistance and enhanced disease control, using a helium gun, sugarcane has been transformed with a UBI-bar construct and selected for resistance to bialophos.) Using a herbicide resistance gene as a selectable 10 marker for transformed plants, we will bombard embryogenic callus from sugarcane and sorghum with plasmid DNA containing sequences coding for lytic peptides. Expression of these cDNAs linked to the maize ubiquitin promoter will be assayed in transgenic plants by Northern 15 and Western blots. Peptide activity will be estimated by tissue extraction, dialysis and bioassays. Transgenic plants will be field grown for preliminary processing experiments. 20 EXAMPLE 2 MOLECULAR FARMING, WITH TRANSGENIC GRAMINEOUS CROPS In this example, sugarcane and sorghum are also used to express lyric peptides and proteins that have high 25 value as pharmaceuticals or biopesticides. As noted, we have developed a reproducible biolistic based transformation and regeneration system for creating transgenic herbicide resistant sugarcane (Gallo-Meagher and Irvine, 1993; 1995) and have made significant progress 30 in biolistic transformation of sorghum. We have also obtained from industrial collaborators cDNAs that code for lytic peptides or proteins that have high value as pharmaceuticals or biopesticides. Specifically, this example relates to 35 transgenically expressing in sugarcane and sorghum the cDNA coding for bovine lysozyme, a potent broad spectrum bactericidal protein found in cow rennin (Mirkov and Fitzmaurice, 1991). This protein has many potential uses H:\terryr\Keep\Retype\P63733 - Amended Speci - Texas T & M - Oct 2007.doc 15/10/07 - 19 in the biopesticide industry. For example, we have shown that the purified protein is extremely effective in decontaminating bacterial infested seed, is an effective topical agent for both prophylactic and curative uses, and 5 that transgenic plants expressing bovine lysozyme are resistant to bacterial infection (Mirkov and Fitzmaurice, 1991). We have successfully expressed the cDNA for bovine lysozyme in tobacco, potato, tomato, and rice (Mirkov and Fitzmaurice, 1991). We also intend to express the cDNA 10 coding for the Pepridyl MINe DEM C-1. We have obtained this gene from Demeter Biotechnologies, Ltd. They have demonstrated that this bio-compound is an effective~ antimicrobial against plant and animal diseases. The volume and price at which these kinds of 15 therapeutic proteins can be produced will determine to what extent they will be available for use. Current production methods are too expensive to allow for widespread market penetration. The cost of production of Peptidyl MIMTM can be as much as $10,000 per gram when 20 produced synthetically, and bovine lysozyme has not been synthesised. In recombinant yeast expression systems, the cost of production ranges from a low of $2.00 per gram for certain Peptidyl MhffM to $1,000 per gram for bovine lysozyme. Based on current expression levels of 25 heterologous proteins being achieved in transgenic plants, we expect to be able to produce these proteins for as low as 0.5 cents per gram using sugarcane and sorghum as recombinant expression systems. This production cost would allow for widespread penetration into new markets. 30 This proposed work relates directly to creating transgenic disease and insect resistant sugarcane. Methodolocrv Using standard molecular biology techniques, the 35 bovine-lysozyme gene (Mirkov and Fitzmaurice, 1991) and the gene encoding the Peplidyl Mlf"m DEM C-1 will be fused between the maize ubiquitin promoter (this promoter is a - 20 strong constitutive promoter in the Gramineae) and the nopaline synthase transcriptional terminator in a high copy number plasmid. This construct will be used in biolistic co-transformation experiments using the maize 5 ubiquitin/bar gene construct (resistance to the herbicides Ignite and Herbeace) as the selectable marker (Gallo Meagher and Irvine, 1993; 1995). The initial sugarcane cultivar to be transformed will be CP70-321 as it is the most widely grown cultivar in Texas, and is easy to 10 regenerate. The grain sorghum variety Pioneer 8313 will be used initially as we have been able to generate embryogenic calli from floral meristems, have regenerated plants from this tissue, and it is widely grown in south Texas. Targets of embryogenic calli will be produced by 15 culturing immature flower inflorescences on MS medium supplemented with 3mg/l 2,4-D (Gallo-Meagher and Irvine, 1995). These embryogenic calli will be bombarded (using a helium driven particle inflow gun) with tungsten particles coated with the, appropriate plasmid DNAs to provide 4pg 20 per shot (Gallo-Meagher and Irvine, 1993; 1995). Plants will be cultured on MS medium supplemented with 3mg/l 2,4 D and 5mg/l Ignite. After four weeks, Ignite resistant calli will be transferred to MS medium supplemented with lmg/l 2,4-D and 5mg/l Ignite to promote shoot regeneration 25 (Gallo-Meagher and Irvine, 19953). Shoots will be subcultured every two weeks on this medium for two months at which time they will be placed on rooting medium containing Ignite (Gallo-Meagher and Irvine, 1995). Plants displaying well developed roots will be screened 30 for the presence and expression of the transgene by PCR and Western blot analyses. A set of the highest expressors will be grown in the greenhouse. The transgenically expressed proteins will be partially purified from these transgenic plants using tissue 35 extraction, dialysis, and differential ultrafiltration. The protein activity will be bioassayed using several species of plant pathogenic bacteria for the generation of - 21 kill curves. Further purification and bioassays will be carried out. Small plots of these transgenic plants will then be field grown for initial pilot plant processing experiments to be conducted using the pilot plant located 5 at the sugar mill in Santa Rosa, TX. Transgenically ' expressed peptides and proteins would be expected in the normally discarded residue of the first processing step after milling, juice clarification. This juice will be used as the starting material for partial purification and 10 bioassays as described above. Planned steps include: Construction of the plasmids. for transformations Introduction into targets of sugarcane variety CP70-321 and sorghum Pioneer 8313 15 Tissue culture and regeneration of plantlets Screening for the presence and the expression of the transgenes Partial purification and bioassays Field trials and initial pilot plant processing 20 experiments Transgenic plants would be made available to growers immediately at the end of this study. The transgenic plants would then be processed in a normal fashion at the sugar mill to obtain the sugar. The 25 normally-discarded juice containing the value added peptides and proteins could then be purified further and the proteins and peptides marketed. EXAMPLE 3 ENGINEERING RESISTANCE TO SUGARCANE MOSAIC 30 VIRUS Sugarcane mosaic virus (SCMV) and sorghum mosaic virus (SrMV) are aphid transmitted potyviruses with single stranded RNA genomes. There are several strains that cause significant losses in sugarcane growing areas 35 throughout the world. These viruses have been difficult to control in cultivated varieties by the transfer of virus resistance genes from naturally resistant varieties - 22 through traditional breeding programs. However, it has now been demonstrated that it is possible to control potyviruses very effectively by genetic engineering. This technique is known as "coat protein-mediated resistance" 5 and is a form of pathogen derived resistance. It has been demonstrated for many viruses, and in many plants, that the virus is controlled by transforming the plant with the virus gene that produces its coat protein. Furthermore, production of transgenic sugarcane is now a routine 10 procedure in our laboratories. A project has been initiated to produce transgenic sugarcane plants that express the coat protein gene of SrMV strain H, to produce resistance to this and other closely related strains of SCWV. This engineered 15 resistance would be monogenic and, therefore, easily transferred to other sugarcane varieties by conventional plant breeding methods. EXAMPLE 4 ENGINEERING RESISTANCE TO SUGARCANE MOSAIC 20 VIRUS Sugarcane mosaic was discovered in Louisiana by Brandes in the early part of the 20" century and the virus has evolved into different strains. Currently, Texas has one (strain H) of the world's 15 reported strains. 25 Breeders found resistant varieties for early strains only to have them succumb to a new strain. This search and replace strategy has been the only source of mosaic resistance. However, it is now possible to control potyviruses, and the sugarcane mosaic.virus (SCMV) is one, 30 through coat protein-mediated resistance.*. Many plants have been given coat protein genes from viruses and have become resistant to the pathogen. The same strategy should work with sugarcane. We have developed a technique for routinely 35 inserting foreign genes into sugarcane. A collection of all SCMV strains available in the US has been established and the coat protein gene for SCMV strain H has been - 23 removed from the virus and its sequence determined. We propose to use several plasmids with the SCMV H coat protein and the UBI-bar selectable marker construct, and produce transgenic versions of Nco 310 and 5 CP72-1210 that are resistant to sugarcane mosaic. The resistance engineered into these varieties could be transferred through conventional breeding. EXAMPLE 5 CONTROL OF MELON DISEASES USING TRANSGENIC 10 PLANT TECHNOLOGIES Genetic engineering approaches may be used to incorporate disease and insect resistance genes int-o melon varieties, such as those important to southern Texas agriculture. This would allow a reduction in the amounts 15 of pesticides currently being used, while maintaining or increasing production levels. Target genes include virus and whitefly resistance. EXAMPLE 6. CONTROL OF PLANT DISEASES AND INSECTS AND 20 OTHER DESIRED TRAITS USING TRANSGENIC PLANT TECHNOLOGIES Using recombinant DNA technology, desired plant viral genes, and genes encoding lectins or lectin-like proteins, *or bovine lysozyme, will be used to create 25 constructs to allow for the desired expression in plants. These constructs will be utilised to create transgenic plants which will be evaluated for viral, bacterial, and insect resistance/immunity. 30 EXAMPLE 7 LAMBDA GENOMIC LIBRARY CONSTRUCTION For successful construction. of a genomic library, the length of the starting DNA is very important. Fragments of DNA with one sheared end and one-restriction -enzyme-generated end compete for lambda DNA in the 35 ligation reaction and decrease the formation rate of concatemers that can be packaged into bacteriophage. X particles. To avoid this problem, the length of starting -24 DNA should be at least fourfold longer than the partial digestion products used to construct the library. Young leaves of sugarcane cultivars, CP65-357 and CP72-1210 were cut into small pieces and wrapped with 5 foil, frozen immediately in liquid nitrogen and then stored at -70*C. Genomic DNA (about 100kb) was isolated from frozen leaves using a CTAB method (Honeycutt et al., 1992). This method yields good quality initial DNA when using fresh tissue, a wide-bore pipette and no shaking 10 during preparation. Sugarcane genomic DNA was partially digested with Sau3A1 (NEB). Restriction enzyme digestion conditions were optimised on a small scale before performing large scale digestions of genomic DNA for preparation of a -15 genomic library. In a small-scale reaction, 1g of genomic DNA was digested for 30min with a serial dilution of Sau3A1 ranging in concentration from 0.0035-lunit/50pl reaction. The digested DNA was run on a 0.4070 agarose gel along with DNA markers (Lambda DNA/HindIII Markers). 20 The gel was photographed, and the amount of enzyme needed to produce the maximum intensity of fluorescence in the size range from 15-23kb was determined. Using the optimised conditions determined above, a large-scale reaction with 100g genomic DNA was carried out. The 25 digested DNA was size fractionated by preparative agarose gel electrophoresis. DNA in the 10-23kb range was cut out, digested with GELase (Epicentre Technologies, Madison W1) according to the manufacturer's protocol then precipitated with ethanol. The isolated DNA fraction was 30 run on a 0.4% gel to confirm the size of genomic DNA. The vector used for genomic library construction was Lambda Dash (Stratagene). The Lambda DASH II system takes advantage of spi (sensitive to P2 inhibition) selection. Lambda phages containing active red and gam 35 genes are unable to grow on host strains that contain P2 phage lysogens. When an insert replaces the stuffer fragment, the recombinant lambda DASH II phage is able to - 25 grow on the P2 lysogenic strain. Therefore, by plating the library on the XLl-blue MRA (P2) strain, only recombinant phages are allowed to grow. The fractionated DNA was ligated to Lambda DASH 5 II /BamHI arms (Stratagene) at a ratio of 400ng insert to 1g of arms in a total volume of 5pl per reaction. The ligations were carried out at 160C overnight. The ligation solution was then packaged with both Gigapack III Gold packaging extract (Stratagene) and Packagene extract 10 (Promega). The packaged phages were plated on both XLI-Blue MRA and XL1-Blue MRA (P2) host strains after an appropriate dilution. The packaging efficiency of the Gigapack III Gold packaging extract (Stratagene) was 15 slightly higher than the Packagene extract (Promega). The titers of packaging reaction are shown in Table 1. About 1 x 106 plaques were amplified and this amplified library was used for genomic library screening.
- 26 TABLE 1 COMPARISON OF TITERS (PFU/Rg VECTOR) OF THE GENOMIC LIBRARY PLATED ON THE E. coli XL-1 BLUE HOST STRAIN WHEN USING 5 DIFFERENT PACKAGING EXTRACTS E. coli Host strain XL1-Blue MRA(P2) XL1-Blue MRA (P2) 10 Test 1 Test 2 Gigapack III Gold packaging extract 1.62 x 106 2.06 x 106 (Stratagene) 15 Packagene extract (Promega) 1.25 x 106 1.60 x 106 - 27 EXAMPLE 8 INITIAL GENOMIC LIBRARY SCREENING FOR HIGHLY-EXPRESSED GENES Total RNA was isolated from'leaves of sugarcane cultivar CP72-12 10 based on the method developed by Yang 5 Si in Dr. Paterson's laboratory (pers. Comm.). About Ig plant tissue was frozen in liquid nitrogen and ground into fine powder. This powder was then transferred into a 50ml conical tube containing 10ml ice-cold RNA extraction buffer (200mM Tris-HCl pH8.5, 2% SDS, 10mM Na 2 -EDTA, 1% 10 Sodium deoxycholate and 1% polyvinyl pyrrolidone 40). The powder in solution was blended in a polytron at high speed for 1min after adding 10ml PCI .(phenol:chloroform:i-soamyl alcohol = 25:24:1). 0.45ml of Sodium acetate (3.3M pH5.2) was added to above solution and mixed well. This mixture 15 was kept on ice about 15min to let the RNA diffuse into the aqueous phase. The upper aqueous phase was separated by centrifugation at 3,500 rpm for 20min and transferred to a fresh conical tube. The RNA was precipitated with an equal volume of isopropanol and 1/9 volume of 3.3M NaOAc 20 (pH6.1). The RNA pellet was rinsed with 70%(v/v) ethanol, and allowed to air-dry. The pellet was dissolved in 800p1l H20, mixed with 200pl 10M LiCl and incubated an ice about 5-12h. This solution was then centrifuged at 12,000 rpm. for 15min and the pellet was resuspended in 400pl H 2 0, and 25 mixed with 600pl 5M KOAc (pH not adjusted). The mixture was incubated again in ice for 3h and centrifuged at 12,000 rpm for 20min. In this step, the RNA pellet was freed of DNA and LiCl, and resuspended in 200p1l H 2 0, then precipitated with ethanol. The RNA pellet was washed with 30 70% ethanol and vacuum dried for 3-5min before being dissolved in 600pl H20. The RNA was then ready for electrophoresis and column chromatography for- Poly A* RNA isolation. The quality of RNA preparation was checked by 35 loading 1pg of RNA on a 1% agarose gel in 1 x TAE electrophoresis buffer, prepared in a RNase-free way. No high molecular weight bands (>20 kb) were visible (sign of - 28 DNA contamination) and rRNA bands were distinct under UV illumination. Poly A* RNA was isolated from total RNA prepared above using Oligo (dT) Cellulose (NEB cat. #1401) 5 according to the manufacturer's instructions. Twice column-purified mRNA was then used for cDNA synthesis. The poly A+ RNA isolated above served as a template for synthesis of first strand cDNA by transcribing into first strand cDNA with BRL Superscript 10 reverse transcriptase using oligo (dT) 12-18 as a primer. About 0.5-1gg mRNA was first mixed with 0.5pg Oligo (dT) 12-18, incubated at 70 0 C for 10min, and placed on ice for 2min. The reverse transcription buffer; dNTP mix, a 3p dCTP and reverse transcriptase were then added to the 15 above solution. The final reaction solution contained 20mM Tris-HCl (pH8.4), 50mM KCl, 2.5mM MgCl 2 , 10mM DTT, 0.3mM each dATP, dGTP, dTTP and 2pM dCTP and 9gl of 6,000 Ci/Mol (X- 32 P dCTP and 1pl SuperScript II RT (200units/l, BRL). The reaction was incubated at 42*C for 50min, and 20 the probe was denatured with 0.2N NaOH for 15min. The denatured cDNA probe was added to hybridisation buffer for library screening. For screening, it was important to maintain individual plaques (plaques should not touch each other) 25 in order to clearly distinguish recombinants. The genomic library was plated on 100 x 15mm petri dishes with NZY agar medium at a density about 5,000 plaques per plate. The plates were incubated at 37 0 C for approximately 8-10h, or until plaques were pinpoint-sized. 30 To harden the agarose, the plates were placed at 4*C for at least 60min prior to lifting. The Hybond-N' (Amersham) filters were labelled with water insoluble ink and.progressively placed on the plates. To orient the filter to the plate, a 21-gauge needle (black ink 35 attached) was stabbed through the filter into the agar asymmetrically at three points around the edge of the plate. The plaques were allowed to transfer for 3min for - 29 the first lift and 5min for the second lift. The filters were removed from the plates and placed plaque side up on a sheet of 3MM paper. The nylon filters were denatured after lifting by 5 placing the membrane for 7min on a pad of absorbent filter paper soaked in 1.5M NaCl and 0.5M NaOH. They were then neutralised an a pad of filter paper soaked in 1.5M NaCl and 0.5M Tris-HCl (pH7.2) for 3min and then repeated with a fresh solution. The membranes were rinsed for no more 10 than 30s by submerging the membrane in a 2 x SSC solution and transferred to dry filter paper to air dry. The phage DNA was fixed by placing the membrane on a pad of absorbent filter paper soaked in 0.4M NaOH for 20min. The membranes were rinsed by immersion in 5 x SSC 15 with gentle agitation for no more than 1min. The membranes were then hybridized with.the 1 st strand cDNA probe. In total about 100,000 plaques were cultivated and screened with pooled lt strand cDNA probe. Two steps were used in the first screening: In 20 the first stage,.1 x 105 phages separated on 20 plates were screened by first strand cDNA to identify the clones with a strong hybridization signal. Because -some of clones with high signal might contain rDNA, or other highly repetitive sequences, further testing was needed. In the 25 second stage, the same set of 20 filters were stripped and. probed with poly A (-) RNA. The test result showed that most of the clones with a strong hybridisation signal did not hybridise with poly A (-) RNA. About 29 genomic clones which showed very strong hybridisation signals in 30 the primary screening, but did not hybridise with poly A (-) RNA, were selected for secondary and tertiary screening. only 12 clones showed very strong hybridisation signals under the secondary and tertiary screening, and were selected for further characterisation. 35 EXAMPLE 9 CONSTRUCTION OF cDNA LIBRARY Poly A (+) RNA was isolated from leaf total RNA - 30 of sugarcane CP72-2086 using a Poly Quick mRNA isolation Kit (Stratagene) based on the manufacturer's protocol. Single strand and double stranded cDNA were produced from 5pg poly A (+) RNA. The library was constructed in the 5 Uni-ZAP XR vector (Stratagene). The primer was a 50-base oligonucleotide containing an XhoI restriction enzyme recognition site and an 18-base poly (dT). The poly (dT) region binds to the 3' poly (A) region of the mRNA template, and MMLV-RT begins to synthesise the first 10 strand cDNA. The second strand cDNA was synthesised by RNase H and DNA polymerase I. Finally, EcoRI adapters were ligated with the termini of double-stranded cDNA, and XhoI digestion released the EcoRI adapter and residual linker-primer from the 3' end of the cDNA. The size 15 fractionated cDNA had an XhoI site at the 5' end and an EcoRI site at the 3' end. These cDNA inserts were ligated with EcoRI/XhoI double digested vector and packaged in Gigapack III Gold packaging extract. The packaged phages were plated on the E. coli cell line XL1-Blue MRF. About 20 1 X 106 primary clones were amplified and this amplified cDNA library was further screened by DNA probes. EXAMPLE 10 PURIFICATION OF LAMBDA PHAGE DNA AND RESTRICTION ENZYME MAPPING 25 The recombinant phage DNA of.the twelve identified clones in Example 8.were purified from liquid lysates following a miniprep protocol (Elgar 1997). Briefly, 20ml of liquid lysate was incubated with DNase I and RNase (final concentration lpg/ml) at 37*C for 30min. 30 About 1/5 volume of PEG solution (3M NaCl, 30% PEG) was then added to the above solution and left on ice overnight. The above mixture was centrifuged at 10,000rpm for 20min. The pellet (PEG-phage complex) was resuspended in 400Ll STE buffer. An equal volume of 4% SDS was added 35 and the solution incubated at 70*C for 20min. 400gl 3M KOAc (pH5.6) was subsequently added after cooling on ice for 5min. The resulting solution was centrifuged at 12,000rpm - 31 f or 10min at 4*C to remove debris. The supernatant was then precipitated with an equal volume of isopropanol, and the pellet resuspended in H 2 0, and stored at -20 0 C. The phage DNA from the selected 12 clOnes was 5 digested with BamHI, EcoRI, and BamH1 + EcoRI. These restriction enzymes were the cloning sites of the vector and did not cut the vector arms. The digestion was run on a 0.8% agarose Tris-borate-EDTA (TBE) gel. All 12 clones had three bands in common which were the left and right 10 arms. The restriction digestion pattern for clone.9-1 and 9-2 was exactly the same. All the other clones showed different restriction fragment patterns. To determine which fragments contained the coding region, a Southern blot was made from the gel. This 15 Southern blot was hybridized with pooled first strand cDNA derived from poly A (+) RNA as described in Example 8. The fragments which hybridized with pooled cDNA contained the coding regions of highly expressed genes. In order to determine whether any of the 12 20 clones contained ubiquitin genes, the above filter was stripped and hybridized with a subclone from the cDNA of p6t7.2bI (Christensen et al. 1992). The X phage Southern blot analysis with ubiquitin cDNA probe indicated that A phage clone 15-1 actually contained the ubiquitin gene 25 . (Data not shown). The relative signal intensity of each lane, which may be related to abundance of the selected gene, can be revealed from the signal intensity-comparison between a selected clone and ubiquitin (ubi) genomic clone 15-1. The 30 mRNA expression level of genes represented by clones 10-1 and 14-1 was much higher than ubi. Clones 9-1, 14-2, 16 1, 17-2, 18-1 and 19-1 probably contained genes with expression levels similar to ubi. Clones 8-1 and 21-1 had genes for which the expression level was lower than Ubi. 35 The 8 genomic clones 9-1, 10-1, 14-1, 14-2, 16-1, 17-2, 18-1 and 19-1 which had a similar or higher expression level, compared to ubi, were selected as probes - 32 for cDNA library screening. The restriction fragments of . phage genomic clones containing the coding region served as probes to screen the sugarcane leaf cDNA library. About 10-20 cDNA clones were isolated from the sugarcane 5 leaf cDNA library for each genomic clone. The hybridisation results showed that clones 10-1 and 14-1 contained the same gene. Also 14-2, 17-2 and 18-1 hybridized with same cDNA clones. So, in total, 5 different genes were found following the cDNA screening. 10 The recombinant cDNA inserts were converted to plasmids by in vivo excision according to Stratagene's protocol, leaving the cDNA inserts in the Bluescript SK plasmid vector with T3 and T7 promoters-flanking the cDNA insert. 15 Briefly, the plaques of interest from the agar plate were transferred to individual sterile microcentrifuge tubes containing 5001l of SM buffer and 20l .chloroform and stored overnight at 4*C or until used. The XL1-Blue MRF and SOLR cells were grown overnight in LB 20 broth supplemented with 0.2% (w/v) maltose and 10mM MgSO 4 at 300C. The three components: 200)1 XL1-Blue MRF cells at an OD 600 of 1.0; 250sl phage stock and 1pl ExAssist helper phage (> 1 x 106), were mixed in a Falcon 2059 polypropylene tube. The Falcon 2059 polypropylene tube 25. was, incubated at 37 0 C for 15min, then 3ml of LB broth was added and shaken at 37*C for 2.5-3h. The Falcon tube was heated at 68-70*C for 20min and spun at 1,000 x g for 15min. The supernatant contained the excised pBluescript phagemid packaged as filamentous phage partcles and 14l of 30 this supernatant was added to 2001 of freshly grown SOLR cells at OD 600 1.0. The cell mixture was incubated at 370C for 15min and placed on LB-ampicillin agar plates and incubated overnight. The cDNA insert were isolated by'enzyme, 35 digestion with EcoRI and XhoI, or by PCR. All the cDNA clones were sequenced using T3 and T7 primers using the ABI Prism dRhodamine Terminator Cycle - 33.
Sequencing Ready Reaction Kit. BLAST similarity searches based on partial sequences of both 5' and 3' of cDNA inserts indicated that 4 out of the 5 cDNAs clones were similar to known genes. Only one of them (14-2) did not 5 show significant similarity with any genes in GenBank. TECHNIQUES USED SOUTHERN BLOT ANALYSIS 10 Ten pg of total genomic DNA isolated from sugarcane leaves (Honeycutt et al, 1992) was digested completely with restriction enzymes, electrophoresea on a 0.8% agarose gel overnight, and transferred to a Hybond N* membrane (Amersham) in 0.4N NaOH for 24h. The membrane 15 was rinsed once with 2 x SSC for 1min. The membrane filters were prehybridised overnight at 65 0 C with gentle agitation in prehybridisation solution containing 5 X SSC, 5 x Denhardt's solution, 0.5% (w/v) SDS and 50gg/ml denatured herring sperm DNA. The DNA probes prepared for 20 Southern blot analysis were based on random hexamer labelling. To carry out the labelling procedure, the DNA of interest was digested with an appropriate restriction endonuclease. The DNA fragment of interest was recovered by gel electrophoresis and GELase extraction (Epicentre 25 Technologies) according to the manufacturer's protocol.. The purified DNA fragments were denatured by boiling, annealed to random hexanucleotides, then incubated with Klenow fragment in a total volume of 50pl solution containing 50mM Tris-HCl (pH8.0), 5mM MgCl 2 , 2 mM DTT, 20pM 30 (dATP + dTTP + dGTP), 0.2M HEPES (pH6.6), 50gCi 6,000. Ci/mmol [a- 32 JP dCTP and 1pl Klenow.. The reaction was carried out at 37 0 C for 1h and the labelled DNA was separated from unincorporated radioactive precursors by chromatography.on a small Sephadex G-50 column. The 35 purified probe after labelling was denatured by adding one volume of 0.4N NaOH for 15min, and then added to hybridisation solution. The hybridisation- box was - 34 incubated at 65*C overnight in a shaker at 50rpm. NORTHERN BLOT ANALYSIS 10-30gg of total RNA isolated from root, stern 5 and leaf of sugarcane were separated on a 1.2% formaldehyde/agarose gel containing 7% formaldehyde and 1 x MOPS buffer. The gel was run in 1 x MOPS buffer at 3-4 V/cm for 3h or until the bromophenol blue band migrated approximately 8cm. The RNA ladder was cut out, stained 10 with ethidium bromide, and photographed under'UV light to . estimate the size of the RNA samples. The portion of the gel to be transferred to nitrocellulose was not stained, but placed in a large tray and rinsed several times with water to remove the formaldehyde. The RNA was transferred 15 to a nylon membrane-Hybond N* (Amersham) with 10 x SSC and fixed by baking the filter for 2h at 80 0 C. The membrane was hybridised with a cDNA probe. The procedure of prehybridisation and hybridisation was the same as the Southern hybridisation. 20 SEQUENCING OF cDNA CLONES All cDNA clones selected from the cDNA library were in the pBluescript SK plasmid vector with T3 and T7 promoters flanking the cDNA insert. The cDNA clones were 25 first sequenced.using T3 and T7 primers and further sequencing by designing internal primers. The sequencing reaction was performed according to ABI PRISM dRhodamine Terminator Cycle Sequencing Ready Reaction kit and run on an ABI 377. 30 SUBCLONING AND SEQUENCING OF LAMBDA GENOMIC CLONES CONTAINING 5' UPSTREAM SEQUENCES A fraction of 5' cDNA which was about 100bp in length, was used as a probe for hybridisation with 35 Southern blot filters made from X phage DNA digested with different enzymes. The fragments which were hybridised with the 5' end of the cDNA, were isolated and cloned into - 35 the pBluescript SK plasmid at the respective restriction sites. The positive subclones were confirmed by blue/white selection and restriction enzyme digestion. The subclones were further analyzed by sequencing. 5 PRIMER EXTENSION AND MANUAL SEQUENCING The transcriptional initiation sites were determined by primer extension analysis according to the method developed by Dias (1995) with some modifications. 10 Two 30-mer primers, both complementary to nucleotides near the translation start site, were synthesised and end labelled with ['- 32 P] ATP and T4 polynucleotide kinase. Each labelled primer (lpMol each)'was annealed to 1 g mRNA or 151Lg total RNA isolated from sugarcane leaves by heating 15 to 65*C for 5min and incubating at 50 0 C for lh. The annealed RNA/primer mixture was mixed with reverse transcription buffer in a total volume of 20gl and then extended for 60min at 50*C using 200U of Superscript. reverse transcriptase II (Gibco BRL). The RNA was 20 denatured by addition of 8pl of 1N NaOH and incubation for 30min at 50 0 C, neutralised with 5pil of 3M sodium acetate pHS.5, and precipitated by addition of 2 volumes of ethanol. The pellet was dissolved in 3pl of TE buffer (pH8.0) and 2gl formamide stop solution. The primer 25 extended cDNA products were analyzed by electrophoresis on a 6% urea-polyacrylamide gel in parallel with a sequencing ladder generated with the same primer and corresponding genomic clone as template. Manual sequencing was conducted using Sequitherm Cycle Sequencing Kit (Epicentre 30 Technologies, Madison, WI) with a- 32 PdATP. EXAMPLE -11 MAPPING OF HIGHLY-EXPRESSED SUGARCANE GENES ON THE SORGHUM AND SUGARCANE GENETIC MAPS Four.of the five genes isolated could be mapped 35 on an interspecific F2 cross between S. bicolor and S. propinquum (Chittenden et al. 1994). The PRP gene is located on linkage group E. AQ1 is located on linkage - 36 group F. The unknown clone 14-2 and EFla gene are both located on linkage group I. The relative chromosomal locations in maize. rice and wheat were inferred and shown in FIG. 1. 5 The sugarcane RFLP mapping were done in two interspecific F1 populations. They were derived from crosses between heterozygous parents: (1) 85 F1 plants from S. officinarum Green German (GG, 2n = 97-117) x S. spontaneum IND 81-146 (IND, 2n = 52-56); (2) 85 Fl plants 10 from S. officinarum Muntok Java (MJ, 2n = 140) x S. spontaneum PIN 84-1 (PIN, 2n = 96). Further details regarding the mapping population, as well as lab techniques, data analysis, and nomenclature for loci and "Linkage groups" are described by Ning et al., 1998. Two 15 cDNA clones, MZY 9-1 (STUB) and MZY 14-1 (SPRP) detected restriction fragment length polymorphisms and fit 1:1 ratios. The map locations in sugarcane linkage groups are shown in FIG. 2. There are multiple loci for each probe. MZY 9-1 detected 3 loci and MZY 14-1 detected 6 loci. 20 EXAMPLE 12 cDNA CLONE AND GENOMIC CLONE OF SUGARCANE PROLINE-RICH PROTEIN (SPRP1) The first gene studied was the proline-rich protein (PRP). This gene showed an extremely strong 25 signal when hybridised with pooled first strand cDNA. The proline-rich protein was highly expressed in leaf and stem, but expressed at low levels in roots. Calculation of the signal intensity using the Kodak ID image software indicated that the expression level of SPRP in leaf was 30 about 20 times higher than in root and 3 times higher than in stem. A cDNA clone SPRPI had an insert size of approximately 1.2 kb. This clone was initially sequenced. The nucleotide and deduced amino acid sequence is shown in 35 FIG. 3. Both nucleotide and amino acid sequences have the greatest similarity to a maize proline rich protein (Accession number Y17332) and wheat proline-rich protein (Raines et al., 1991). A computer search of the nucleotide H.\terryr\Keep\Retype\P63 7 33 - Amended Speci - Texas T & M - Oct 2007.doC 15/10/07 - 37 sequences in the GenBank database (July, 1999) revealed 73% identity between sugarcane and maize, and 70% identity between sugarcane and wheat. The comparison of the deduced amino acid sequences showed that sugarcane PRP has 5 78% similarity with maize and 77% similarity with wheat. The translation analysis showed that this cDNA clone was not full-length, lacking the 5' end but with 184 bp of 3' non-coding sequence. The predicted peptide sequence from this partial cDNA is shown in FIG. 4 and reveals that the 10 peptide is very rich in proline (near 50%), lysine, and glutamic acid. It has a highly repetitive amino acid sequence in the middle of the peptide. The repeat unit PEPK also exists in the wheat proline-rich protein (Raines. et al., 1991) and the maize proline-rich protein 15 (accession number Y17332). The 5'-end sequence of SPRP was obtained from a longer cDNA clone (SPRP2). The 5' end nucleotide sequence of this longest cDNA from sugarcane together with its deduced amino acid sequence is shown in FIG. 4. This cDNA clone contains 99 bp of 5' non-coding 20 sequence with one possible translation start site (ATG). As expected overlapping sequences were found between SPRP1 and SPRP2 cDNA. There was 93% nucleotide sequence identity between these two cDNA in 300 bp overlapping region. The hydrophobicity profile of both SPRP1 and 25 SPRP2 deduced amino acid sequence is shown in FIG. 5. The sugarcane gene we isolated here has common structural features with the previously published wheat PRP sequence (Raines et al., 1991) and a maize proline-rich protein. It has a hydrophilic N-terminal region which is common to 30 Pro-rich cell wall proteins (John and Koller, 1995), a high proline content, and is preceded by a hydrophobic signal peptide. This suggests that the SPRP protein may be a cell wall protein. Four genomic clones (clone number 10-1, 14-1, 28 35 1 and 30-1) of the PRP genes were found by screening of the genomic library. Two clones were chosen for further subclonling and analysis. An 8.0 kb EcoRI fragment from genomic clone 10-1 and a 5.7 kb XboI fragment from genomic H:\terryr\Keep\Retype\P 63733 - Amended Speci - Texas T & M - Oct 2007.doc 15/10/07 - 38 clone 30-1 were subcloned into the pBluescript SK plasmid vector. These genomic subclones were further sequenced. Partial sequencing results showed that the XbaI site was very close to the transcription start site. Therefore, 5 the 5.7 kb XbaI subclone does not have the complete promoter of PRP. Detailed sequencing was done on the 8 kb subclone EcoRI fragment which contained both the promoter and coding region. A total of 1.7 kb, of upstream sequence from the translation start site of PRP was 10 sequenced from this clone (FIG. 6) . Sequence analysis revealed that the promoter contained several important cis-elements. There is a consensus TATAAA box 172bp upstream from the translation start codon ATG. These results indicated that the deduced translation start site 15 might actually function in vivo. A sequence (5'-CCATC) resembling a CAAT box was found 37bp upstream of the TATA box. The base composition plot (FIG. 7) of promoter and 5' coding regions showed that some regions of the promoter are AT rich. 20 Beside the previous Southern analysis among several varieties of sugarcane, another Southern analysis was performed for sugarcane hybrid CP65-357. There was no EcoRI, XbaI, BamHI or XhoI internal restriction sites in the 1.2 kb, PRP cDNA probe (FIG. 8). The number of bands 25 in CP65-357 varied from 3 to 7 depending on which enzymes were used. This suggested again. that the SPRP might be a small gene family in the sugarcane genome. EXAMPLE 13 ISOLATION, IDENTIFICATION, AND 30 CHARACTERISATION OF THE ELONGATION FACTOR la (EFla) GENE AND ITS 5' UPSTREAM SEQUENCE Another interesting clone was elongation factor lax. There are two reasons we chose this gene: First, the 35 phage genomic clones of Southern blot with first strand cDNA indicated that the mRNA level of the EFla. was similar to. that of ubiquitin. Second, the genomic clone we chose contained the entire coding region of elongation factor 1a H:\terryr\Keep\Retype\P 63733 - Amended Speci - Texas T & M - Oct 2007.doc 15/10/07 - 39 based on the Southern blot analysis. Therefore, we isolated three cDNA clones after cDNA library screening with the EFla genomic clone. One of them was a nearly full-length cDNA clone (1578bp) and the 5' end of this 5 cDNA was 18bp down stream of ATG translation start size. This cDNA clone was named SEF la and its sequence is shown in FIG. 9. Homology search with the GenBank sequences revealed that the sugarcane EF la clone shows 93% identity to the maize nucleotide sequence and 99% identity or 10 similarity to the maize deduced amino acid sequence (Berberich et al., 1995), respectively. The phage DNA of the EFla genomic clone was digested with various restriction enzymes. The genomic insert in the phage clone was about 17 kb. The restriction map of the cDNA is 15 given in FIG. 10 and most of the enzymes used (e.g. EcoRI and XboI) did not have sites in the coding region. The 9.5 kb EcoRI and 3.5 kb XbaI fragments from phage clone 19-1 were separately subcloned in the pBluescript SK vector. Genomic sequencing was done first on the genomic 20 subclone containing a 3.5 kb XbaI fragment. This subclone contained the entire cDNA sequence, but the ATG translation start site of EFla was located just 377bp downstream from the XM cloning site. Therefore, a complete promoter region was not likely to be found in 25 this subclone. So, another genomic subclone containing a 9.5 kb EcoRI fragment was used for sequencing of the 5' end of the untranslated leader sequence and promoter region. The 4,537 bp genomic sequence of the entire gene including the 5' upstream region is shown in FIG. 11. The 30 genomic sequence matched base by base to the corresponding sugarcane and maize EFla cDNA sequence (Accession number U7259). The comparison between genomic and cDNA sequences showed that there are two introns found. In the genomic clone one of them is located within the 5' non-coding 35 region and is about 597 bp in length. There is a similar report in Arabidopsis AI EFla gene, in which an intron was found in the 5' non-coding region and is important for the expression of EFla gene in leaves (Curie et al, 1991, H\terryr\Keep\Retype\P 63733 - Amended Speci - Texas T & M - Oct 2007.doc 15/10/07 - 40 1993). The second intron (779bp) is located in the coding region. Like other plant introns, these two introns in sugarcane EFla have nearly universally-conserved GT and AG nucleotides at the 5' and 3' ends. They are also strongly 5 enriched in AT nucleotides (FIG. 12) throughout the intron, a feature that is considered to be a requirement of efficient splicing of plant introns (Liu et al. 1996). In order to map the 5' end of the EFla gene, a primer extension reaction was done with a 30bp primer near 10 the translation start site. The transcription start site of EFlcL was estimated by gel electrophoresis in parallel with sequencing of the genomic clone containing the translation start codon. There were two different temperatures used for primer extension. When the primer 15 extension was done at 45 0 C, two bands appeared and no transcription start site (tsp) could be determined. When the reaction temperature was increased to 50 0 C, only one major band appeared. Based on manual sequencing of the genomic clone, the transcription start site (tsp) is 130bp 20 upstream of the translation start site. In order to characterise sequences involved in the regulation of EFla in sugarcane, about 1,300bp of 5' flanking DNA was determined by automated sequencing. This promoter shares the common features of other promoters, 25 with its nucleotide composition rich in AT bases. The putative TATA box (TATAAA) is located at 33bp upstream of deduced transcription start site and a typical CAAT box found in the position 40bp upstream of TATA box. The base composition plot of the entire EF gene apparently reveals 30 a typical and interesting feature of A and T composition of a plant gene (FIG. 19). There are four H:\terryr\Keep\Retype\P6373 3 - Amended Speci - TexaS T & M - Oct 2007.doc 15/10/07 - 40a AT rich regions: the promoter, two introns as well as 3' untranslated sequences. There is only one small GC rich - 41 region, which is in the first exon (untranslated leader sequence). Other embodiments and uses of the invention will be apparent to those skilled in the art from consideration 5 of the specification and practice of the invention disclosed herein. All references cited herein, including all U.S, and foreign patents and patent applications, are specifically and entirely hereby incorporated herein by reference. It is intended that the specification and 10 examples be considered exemplary only. DISCUSSION GENE EXPRESSION AN. PROMOTER ISOLATION 15 The level of gene expression in plants is associated with many factors such as gene copy number, intron, promoter aid untranslated leader sequence. Among these factors, promoter strength is especially important when a foreign gone needs to be expressed at very high 20 levels. Finding highly expressed genes and isolation of their promoters from sugarcane may provide tools that are very useful in sugarcane gene transfer studies. Although the widely-used cauliflower mosaic virus 35S promoter is active in dicot plants, it is less active in monocots 25 (Rotfer -1993). To increase gene expression in monocotyledonous plants, a few promoters have been isolated to replace the 35S promoter in transformation of monocot cells (Last et al., 1991; McElroy et al., 1991; Zhang et al, 1991; Christensen et al., 1992). The 30 ubiquitin promoter has been shown to be the best among the recently-available promoters (Christensen et al., 1992; Gallo-Meagher and Irvine, 1993; Schledzewski and Mendel 1994). However, there are few if any reports in plants that have examined how many kinds of mRNAs may be most 35 abundant in any one species, and whether the abundance of these mRNAs is due to promoter strength or gene copy number. Here we used a new approach to rind highly - 42 expressed gene promoters in sugarcane. There were four steps in this approach. First, a sugarcane X phage library was constructed and pooled mRNA was used as a probe to screen the genomic library. Second, the coding region of 5 these genomic clones was identified by a phage DNA Southern hybridisation with pooled first strand cDNA and corresponding cDNA clones were isolated from a sugarcane cDNA library. Third, the copy number of genes was estimated the cDNA clones and genomic clones. GenBank 10 searching and primer extension analysis. This new approach may help to find new promoters useful in sugarcane conferring high levels of expression of transgenes in sugarcane or other taxa. 15 GENOMIC LIBRARY CONSTRUCTION AND SCREENING A representative genomic library samples each part of the genome to similar degrees. One of most effective way to do this is by physically shearing of the genomic DNA (e.g. sonication); however this makes the 20 ligation of genomic fragments with vector difficult. An easier way to do this is to partially digest genomic DNA with a frequent cutting restriction enzyme (usually a 4 cutter), which generates ends compatible with one of the multiple cloning sites of lambda vectors. Sau3A1 25 recognises the 4-base pair sequence GATC, which occurs on average every 256 bp in DNA with a base composition of 50% [G+C] and therefore it is frequently used in X phage library construction. The number of clones necessary to provide good 30 coverage of the sugarcane genome can be calculated from the equation of Clarke and Carbon (1996). With an average insert size of 15kb, the probability of finding any sequence from the sugarcane genome, range from 2,547 to 3,605Mb for Sacchrum officinarum (Arumuganathan and Earle 35 1991), in a library of 1 x 106 clones would be greater than 0.99. This is equivalent to a 5 genome-equivalent. In reality, using a restriction enzyme may bias the library -43 and it is therefore worth trying to achieve at least lOx coverage. We assumed that haploid genome size of sugarcane cultivar we used is approximately 3,000Mb. The total gene 5 complement of plants is thought to be around 20,000 to 100,000 protein-coding genes. The results from large-. scale sequencing of Arabidopsis indicated one gene every 5kb on average (Bevan et al., 1998). If we suggest that the sugarcane has 20,000 to 100.000 protein coding genes, 10 there would be one gene every 30-150kb on average. That means that every 10 genomic clones have 1-5 different genes if the average insert size of genomic clones ~is 15 kb. Therefore 100,000 genomic clones may have 10,000 different genes or more. The initial experiment was 15 focused on finding the most highly expressed genes in the sugarcane genome. The logic of screening the genomic library instead of a cDNA library is that we can find the genomic clones containing the highly expressed genes immediately without cDNA library construction. This may 20 be especially useful for isolation of genomic clones by screening with mRNA from different tissues or stages of development without cDNA library construction. About 100,000 plaques have been screened with .first strand cDNA. Twenty-four clones wore selected after 25 comparison of signal intensity among these 10,000 phages. Thirteen clones that continued to display strong signal intensity after second and third screening were further investigated. The 4 genomic clones with the strongest signal were the same gene (SPRP). Northern analysis 30 showed that this gene is actually highly expressed. Southern analysis indicated that the copy number of this gene in sugarcane might be low. Based on these results, the promoter of this gene may be a promising candidate to construct a high-expression-vector cassette for sugarcane 35 transformation. This work may provide another method to isolate promoters directly from a genomic library for plant -44 transformation purposes. Ubiquitin is a powerful promoter in sugarcane transformation, and we also picked up the ubiquitin gene after genomic library screening. This indicated that direct genomic library screening instead of 5 cDNA selection, may actually be useful in isolating promoters of highly-expressed genes. It may be especially useful to isolate several different tissue-specific promoters at the same time, without cDNA library construction (although we did construct a cDNA library in 10 this work). There are two steps that can be used for tissue-specific promoter isolation. The first phage selection can be used to identify any genomic clones that contained highly-expressed genes in one-tissue.. The second screening is phage DNA Southern blot or dot blot, 15 which is more sensitive than plaque lifting, to eliminate the highly-expressed genomic clones, which are also expressed in the tissues that are not wanted. The disadvantage of the phage approach is the DNA isolation, which is time consuming, and less DNA yield for each cic.:e 20 compared to plasmid DNA isolation. The long range PCR approach instead of. phage DNA isolation may help to isolate tissue-specific promoters more easily and quickly. Hundreds of phages can be picked up in the.first screening and selected in the second screening using MMA from 25 different tissues. Sequence database searches may help us to easily predict the promoter region. cDNA LIBRARY CONSTRUCTION The quality of a cDNA library is an important 30 parameter in cloning a gene and defining its transcriptional unit. Some problems are commonly observed in cDNA library development. First, cDNA clones may be chimeric (Soares 1994). The strategy in the form of a flow chart for cDNA library construction in 1-ZAP is shown 35 in Figure 20. A high possibility of chimeric clones results from blunt-end ligation of cDNAs during the reaction in which adaptors are ligated to the cDNAs. One - 45 of our cDNA clones was found to have an internal poly T tail which suggested a chimeric clone resulting from blunt end ligation of two cDNA clones in the same direction. Thcre is another possibility of formation of chimeric 5 clones during the ligation of the cDNAs to the cloning vector. However, this event is less likely because the cDNAs have two different ends and three cDNA molecules must be joined together before they can be ligated to a vector molecule. In order to minimise the probability of 10 formation of chimeric clones in the above reactions, the adaptor or vector should be present in excess over the cDNAs. Also, it is important to size-select the cDNAs before ligation (Soares 1994). The problem of chimeric clones may be common in many cDNA libraries, although this 15 problem can be minimised. The chimeric clones can be detected by RT-PCR. A pair of primers from both the 5' and 3' ends of the cDNA sequence will not amplify a cDNA fragment if it is chimeric. The cDNA clone and genomic clone of sugarcane 20 proline-rich protein (SPRP). There are two major structural proteins known to exist in the plant cell wall, the hydroxyproline-rich glycoprotein and glycine-rich protein (Raines et al., 1991). Sequencing and homology analysis of SPRP1 cDNA 25 clones showed that this.gene is highly homologous with wheat WPRP1 (Raines et al, 1991) in both DNA sequence and protein structure. WPPRI was considered a novel cellular protein, which may have a possible role in forming a pan of the cell wall matrix. Northern analysis of WPRPI 30 indicated that this gene is constitutively expressed with a significantly higher level in rapidly dividing or growing tissues. Our data showed the SPRPI gene to be highly expressed in both leaves and stems but only expressed at low levels in the roots. More specific 35 information on the regulation of this gene may be obtained by transformation of sugarcane with the SPRP promoter fused to a reporter gene.
- 46 Southern blot analysis of sorghum and sugarcane genomic DNA using SPRPI cDNA as a probe reveals an interesting pattern of bands. One strongly hybridizing band is seen in both S. propinquum and S. bicolor, 5 suggesting that sorghum may contain only one copy of this .gene. Many fainter bands are seen in Southern blots probed with SPRP1, the presence of these fainter bands suggests that there may also be weakly-homologous sequences in sorghum. There is a similar report for the 10 wheat proline-rich protein (Raines et al., 1991). Many minor bands were visualised on Southern blot of wheat genomic DNA when hybridised with the wheat PRP cDNA. The most interesting feature of the SPRP gefne is that the Southern analysis indicated a low copy number in sorghum, 15 wheat and sugarcane. The high-level gene expression and low copy nature suggest that the promoter of PRP may serve as a good promoter for sugarcane transformation. We isolated the genomic subclone that contains the entire promoter and coding region. About 1.7kb .20 upstream of the translation start site and the region that coded for the 5' end of the cDNA were sequenced. Comparison the nucleotide sequences of the two cDNAs (SPRP1 and SPRP2) to the genomic sequence confirmed that the promoter we isolated here is a promoter of proline 25 ric.h protein gene expression. The genomic.nucleotide sequence shows 100% identity with the 3' end of untranslated region of the SPRP1 cDNA, but only 97% identity among the coding region. In similar, the nucleotide sequence identity of the 3' end untranslated 30 region between genomic clone and SPRP2 is 96%, which is much higher than sequence identity (83%) of the coding region near the 3' end. There is a similar situation between the two cDNAs (SPRP1 and SPRP2), which reveal a higher nucleotide sequence identity (96%) in 3' end 35 untranslated sequence than coding region (88%). The high level of variation in the SPRP coding region is unknown since most of.gene families are more conservative in the - 47 coding region. We did not obtain sequence for the entire coding region of the genomic clone because of a highly repetitive sequence in the middle of the gene. We did not find any introns, in all of the genomic DNA regions that 5 were sequenced. More sequencing needs to be done to find out whether this gene has introns. ISOLATION, IDENTIFICATION AND CHARACTERISATION OF ELONGATION FACTOR la (EFla) GENE AND ITS 5' UPSTREAM 10 SEQUENCE In Arabidopsis thaliana, the protein EFla is encoded by a small multigene family of four members (Al, A2, A3, and A4). The Al promoter has been isolated and its expression pattern has been determined in Arabidopsis 15 (Curie et al., 1991). The Al promoter directed strong transient expression in Arabidopsis transfected protoplasts (Axelos et al., 1989; Curie et al., 1991). In Monocots, a member of the gene family encoding the a subunit translation factor and the corresponding 20 genomic clone has been isolated from maize. There are at least six members of EFla in maize and its expression is differently regulated in leaves and roots under cold stress (Berberich et al, 1995). Although the complete amino acid sequence has been deduced in maize. The 25 promoter and untranslated leader sequences have not been published. The comparison between our genomic sequence and the maize EFla genomic sequence indicated that sugarcane and maize have high similarity in the coding region (95%) and less in the intron region (70%). The 30 comparison between our genomic sequence and maize EFlcc genomic sequence indicated that the maize genomic clones obtained by Berberich et al. (1995) only contained part of the first intron and 5' untranslated region as well as the entire coding region. We isolated the entire EFla gene 35 including the promoter region. The structure of EFla in sugarcane is similar to Arabidopsis. Both have two introns with one located in the untranslated region and the other H:\terryr\Keep\Retype\P63733 - Amended Speci - Texas T & M - Oct 2007.doc 15/10/07 - 48 one in the coding region. The promoter of EFla in sugarcane shows the common features of plant promoters, with a TATA and CAAT box located upstream of the transcription start site. The 5 promoter and untranslated region including the first intron may be fused to a reporter gene and further transgene-expression can be investigated to evaluate EFla regulation.
- 49 REFERENCES Abencibia A, Molina PR, Riva G de la, Sciman-Housein G (1995) Production of transgenic sugarcane - (Saccharum 5 officinarun L.) plants by intact cell electroporation. Plant Cell Rep 14: 305-309. Arencibia A, Vazquez RI, Prieto D, Tellez P, Carmona ER, Coego A, Hernandez L, Riva GA de la, Selman-Housein G 10 (1997) Transgenic sugarcane piano resistant to stem borer attack, Mol Breeding 3: 247-255. Arencibia AD, Carmona ER, Tellez P, Chari MT, Yu SM, Trujillo LE, Oramas P (1998) An efficient protocol for 15 sugarcane (Saccharum spp. L) transformation mediated by Agrobacterium tumefaciens, Transgenic Res 7. 213-222. Arumuganathan K, Earle ED (1991) Nuclear DNA content of some important plant species. Plant Mol Biol Rep 9: 20 208-219. Axelos M, Bardet C, Llboz T, Le Van Thai A, Curle C, Lescure B (1999) The gene family encoding the Arabidopsis thaliana translation elongation factor EF- 1 alpha., 25 molecular cloning, characterization and expression. Mol Gen Genet 219: 106-112 Benfey PN, Ren L, Chua NH (1990) Combinatorial and synergistic properties of CaMV 355 enhancer subdomains. 30 F2Y1BO J 91 1685-1696 Berberich T, Sugawara K, Harada M,. Kusano T (1995) Molecular cloning, characterization and expression of an elongation factor alpha gene in maize. Plant Mol Biol 29: 35 611-6 15 Bevan M, Bancroft I, Bent E, Love K, Goodman H, Dean C, - 50 Bergkamp R, Dirkse WI Van Staveren M, Stiekerna W, Drost L, Ridley P, Hudson SA, Patel K, Murphy G. Piffancill P. Wedler H, Wedler E, Warnbutt R,Weltzenegger T, Pohl TM, Terryn N, Gielen J, Villarroel R, Chalwatzis N (1998) 5 Analysis of 1,9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature .391: 485-8 Bevan MW, FlaveU.R13 (1983) A chimeric antibiotic: resistance gene as a seleeable marker for plant cell 10 transformation. Nature 304: 184-187 Bower R, Birch RG' (1992) Transgenic sugarcane plants via microprojectile bombardment, Plant 1 2:'409-416 15 Bower R, Elliott AR, Potier BAM, Birch RG (1996) High efficiency microprojectile-mediated cotransformation of sugarcane, using visible or selectable markers, Mol Breeding 2; 239-249 20 Callis J, Fromm M, Walbot V (1987) Introns increase gene expression in cultured maize cells. Genes Devl 1183-1200 Callis J, Raasch JA, Vierstra RD (1990) Ubiquitin extension proteins of Arabidopsis thaliana, Structure, 25 localizadon, and expression of their promoters in transgenic tobacco. J Biol Chern 263A2486-12493 Chen G, Rothnie EM, He X, Hahn T, Futterer j (1996) Elements downstream of the rranscription start site 30 enhance the activity of the rice tungro bacilliform virus (RTBV) promoter in protoplasts derived from cultured rice cells. J Virol 70; 8411-8421 Christensen AH, Quail PH (1996) Ubiquitin promoter-based 35 vectors for high-level expression of selectable and/or screenable marker genes in monocoiyiedonous plants. Transgenic Res 5: 213-218 - 51 Christensen AH, Sharrock RA, Quail PH (1992) Maize polyubiquitin genes: structure. thermal perturbation of expression and =script splicing, and promoter activity 5 following transfer to protoplasts by electroporation. Plant Mol Biol 18: 675-689 Curie C, Axelos M, Bardet C, Atanassova R, Chaubet N, Lesture B (1993) Modular organization and development 10 activity of an Arabidopsis thaliww EF-1 alpha gene promoter. Mol Gen Cenet Z38. 428-436 Curie C, Liboz T, Bardet C, Gander E, Medale C, Axelos M, Lescure B (1991) Cis and trans-acting elements involved .in 15 the acdvation of Arabidopsis thaliana A 1 gene encoding the transladon elongation factor EF-1 alpha, Nucleic Acids Res 19: 1305-13 10 D'Hont A, Grivet k Feldmann P, Rao S, Berding N, Glasmann 20 JC (1996) Characterization of the double genome structure of modem sugarcane cultivars (Saccharum spp.) by molecular cytogenciics, Mol Gen Genct 250.. 405-413 Dias MADL (1995) Analysis of water defect stress 25 responsive eDNA clones -and the characterization of the genon* clone of gene " I pS" of Lobiolly pine (Pinus toeda L), Dissertabon, Texas A & M Elgar.G (1997) Preparation of DNA from Hybridization 30 positive phage. In MS. Clark ed., Plant Mo-lecular Biology: a Laboratory manual. Springer-Verlag, Berlin Heidelberg. ppi 13-114 Elornaa P, Helarlutta Y, Griesbach RJ, Koffialnen M, 35 Seppanen P, Teeri TH (1995) Transgene inactivation in Petunia hybrida is influenced by the properties of the foreign gene. Mol Gon Genet 248.. 649-656 -52 Enriquez-Obregon GA, Vazquez.Padron RI, Pr.icto-Sumsonov M, De ]a Riva GA, Sciman-Housein G (1998) Herbicide -resistant sugarcane (Saccharum officinarum L) plants by 5 Agrobacterium-medlated transformadon. Planta 206.. 20-27 FAO statistics, 1986 Food and Agriculture Organization, FAO Production Yearbook, Vol. 40, FAO Stadstics Series No. 76, 'Food and Agricultural Organization, Rome FlayeU R13 10 (1994) Inacdvation of gene expression in plants as a consequence of specific sequence duplication. Proc Nad Acad Sci USA 91; 3490-3496 Fraley RT, Rogers SG, Horsch RB, Sanders PR, Flick JS, 15 Adarns SP, Bittner ML, Brand LA, Fink CL, Fry JS, Galluppi GR, Goldberg 813,. HotTmann NL, Woo SC (1983) Expression of bacterial genes in plant cells, Proc Nail Acad Sci USA 80..4803-4807 20 Gaille DR, Kado CI (1989) A translational enhancer derived from tobacco mosaic virus is functionally equivalent to a Shine-Dalgamo sequence. Proc Nail Acad Sci USA 86.. 129.132 25 Gaille DR, Sleat DE, Watts JW, Turner PC, -Wilson TM (1987) The Y- leader sequence of tobacco mosaic virus RNA enhances the expression of foreign gene transcripts in vitro and in vivo, Nucleic Acids Res IS: 3257-3273 30 Gallie DR, Walbot V (1992) Identification of the modfs within the tobacco mosaic virus Y-leader responsible for enhancing translation, Nucleic Acids Ros 20: 4631-4638 Gallo-Meagher M, Irvine JE (1993) Effects of tissue type 35 and promoter swength on transient GUS expression in sugarcanc following particle bombardment. Plant Cell Rep 12.. 666-670 - 53 Gallo-Meagher M, Irvine JE (1996) Herbicide resistant transgenic sugarcane plants containing the bar gene. Crop Sci 36: 1367-1374 5 Gambley RL, Ford R, Smith GR (1993) Nficroprojectile transformation of sugarcanc meristerns and regeneration of shoots expression beta-glucuronidase. Plant Cell Rep 12; 343-346 10 Grant SR (1999) Dissect.ing the Mechanisms of Posttranscriptiorial Gene Silencing., Divide and Conquer. Cell 96:303 15 Grivet L, D'Hont A, Roques D, Feldmann P, Lanaud C, Glaszmann IC (1996) RFU mapping in cultivated sugarcane (Saccharym spp.); genome organization in a highly polyploid and aneuploid interspecific,hybrid. Genetics 142; 987-1000 20 Hamilton DA, Schwarz YH, Mascarenhas JP (1998) A monocot pollen-sPecific promoter conWns separable pollen-speciric and quantitative elements, Plant Mol Biol 38:663.669 25 Herrera-Estrelia L, Block MY. de Messens E, Hernalsteens jip, van Montagu M, ScheU J (1983) Chimeric genes as dorrinant selectable markers in plant cells. EM30 12. 987-995 30 Holtorf 8, Apel K, Bohlmann HS (1995) Comparison of different constitutive and inducible promoters for the overexpression of transgones in Arabidopsis thaliana, Plant Mol Biol 29.. 637-646 35 Honeycutt RJ, Sobral BWS, Kelm P, Irvine JE 1992 A rapid DNA extraction method for sugarcane and its relatives, Plant Mol Biol Rep 10. 66-72.
- 54 Jobling SA, Gehrice L (1987). Enhanced translation of chimeric messenger RNAs containing a plant viral untranslated leader sequence. Nature 325: 622625 5 John NZ, Keller G (1995) Characterization of mMA for a prolino-rich protein of cotton fiber. Plant Physiol 108; 669-676 10 Kay R, Chan A. Daly M and MePherson J (1987) Duplication of.CaW 35S Promoter sequences creates a strong enhancer for plant genes. Science 236: 1299-302. Konez C, de Greys H, Andre D, Deboeck F, van Montagu M, 15 Schell .J (1983) The opine synthase genes carried by Ti plasmids contain all signaJs necessary for expression in plants. EMBO J 2. 1597-1603. Last DI, Brettell RIS, Chamberlain DA, Chaudbury AM, 20 Larkin PJ, Marsh EL, Peacock W1 Dennis ES (199 1) pEmu: an improved promoter for gene expression in cereal cells. Theor App Genet 81: 58 1 -598. ILW HX, Filipowtcz W (1996) Mapping of branchpoint 25 nuelcotidcs ip mutant pre-mMAs expressed in Plant Cells Plant J 9: 381.389 Luehrsen KR, Walbot V (1994) Addition of A. and U.nich sequence inCreases the Splicing efficiency of a deleted 30 fOrM Of a maize intron, Plant Mol Biol 24.. 449.463 Luehrsen KR, Walhot V (1991) Intron enhancement of gene expression and the splicing efficiency of introns in maize cells. Mol Gen Genet 225: 81-93 35 Maas C, Laufs J, Grant S, Korlhage C, Werr W (1991) The combination of a novel stimulatory element in the first - 55 exon of the rnaize Shrunken-1 gene with the following intron 1 enhances reporter gene expression up zo 1000-fold. Plant Mol Biol 16. .199-207 5 Maid 1B, .Gowda S, Klernan J, Ghosh S K, Shepherd Ri (1997) Promoterlleader deletion analysis and plant expression vectors with the figwort mosaic virus (F" full length transcript (FLT) promoter containing single or double enhancer domains. Transgenic Res 6..143-156. 10 Matzke AJ, Matzkc MA (1998) Position effects and tpigenetic silencing of plant transSenes. Curr Opin Plant Biol L 142-148. 15 Matzke AI, Matzke MA, Logernann J, Willmitzer L, Schell J (1989) Cisanalysis of the wound-inducible promoter wun1 in tmnsgenic tobacco plants and histochernical localization of its expression. Plant Cell 1; 961-968 20 MLatzke MA, NUtzke Al (1998) Gene silencing in plants: relevance for genome evolution and the acquisition of genomic methylarion patterns. Novartis Found Symp 214: 168- 180 25 McElroy D, Blowers AD, Jenes 8, Wu R (1991) Construction of expression vectors based on the rice acdn 1 (Acti) Yregion for use in monocot transformakion. Mol Gen Genet 231: 150-160 30 MeElroy D, Zhang W, Cao J, Wu R (1990) Isolation of an efficienc actin Prornoter for use in n*cc transfOrmation, Plant Cell 2:163.71 Meyer P, Saedler H (1996) Homology-dependent gene 35 silencing in plants. Annu Rev Plant Physiol Plant Mol Biol 41: 23-48.
- 56 N11tra A, Higgins DW (1994) The Chlorella virus adenine methyltransferase gene promoter is a strong promoter in plants. Plant Mol Biol 26: 85-93 5 Odell JT, Nagy F, Chua NH (198s) Identification of DNA sequences required for acdvity of the cauliflower mosaic virus 35S promoter, Nature 313: 6005 Park YD, Moscone EA Papp 1, lgiesias VA, Vaucheret H, 10 Matzke AiM (1996) Gene silencing mediated by promoter homology occurs at the level of transcription and results in meiofically heritable alterations on methylation and gene activity, Plant 19: 193-194. 15 Raines CA, Lloyd JC, Chao SM, John UP, Murphy GJ (1991) A novel proline-rich protein from wheat. Plant Mol Biol 16:663-670 Rathus C, Bower R, Birch RG. (1993) Effects of promoter, 20 intron and enhancer elements on wansient gene expression in sugarcane and carrot protoplasts. Plant Mol Biol 23:613-618 Roach BT (1972) Nobilisation of sugarcane. Proc Int Soc 25 Sugarcanc Tochnol 14:206-216. Slebertz B, Logemann J, WiRmitzer L, Schell j (1989) cis-analysis of the wound-inducible promoter wun I in transgenic tobacco plants and histochernical localization 30 of its expression. Plant Cell L 961.8. Sleat DE, Hull R, Turner PC, Wlhon TM (1988) Studies on the mechanism of translational enhancement by the Y-leader sequence of tobacco mosaic virus RNA. Eur J Biochern 35 175.75-86 Srnirnyagina EV, Morow SY, Rodionova NP, Miroshnichenko - 57 NA, Solovey AGs Fedorkin ON, Atabekov X (1991) Translational efficiency and competitive ability of mRNAs with Y-untranslated alpha beta-leader of potato virus X RNA. Biochide, 73:587-598. 5 Soares KB (1994) Construction of Directional cDNA librasies. Page 110- 114, in book: Automated DNA sequencing and Analysis. Edited by Mark D. Adams 10 Srivastava BL, Cooper M, Mullins RT (1994) Quantitative analysis of the effect of selection history on sugar yield adaptation of sugarcane clones. Theoretical & Applied Genetics 87. 627-640 15 Tanaka A, Mita S, Ohta S, Kyotuka J, Shimamoto K. Nakarnura K (1990) Enhancement of foreign gene expression by a dicot intron in rice but not in tobacco is correlated with an increased level of mRRNA and an efficient splicing of che intron. Nucleic Acids Res 18:6767-6770 20 Tornashevskiya OL, Solovyey AG, Karpova OV, Fedorkin ON, Rodlonova NP, Morozov SYu,.Atabekov JG (1993) Effects of sequence elements in the potato virus X RNA 5'non-translated alpha beta-loader on its translation 25- enhancing activity. 1 -Gen Virol 74: 2717-2724 Topter R, Maas C, Horicke-Grandpierre C, Schell J, Steinbiss HH (1993) Expression vectors for high-level gene expression in dicotyledonous and monocotyledonous plants. 30 Methods Enzymol: 217: 67-78 Voinnet 0, Vain P, AngeU S, Baulcombe DC (1998) Systemic spread of sequence,spccific =sgcnc RNA degradation in plants is initiated by localized introduction of ectopic 35 promoterless DNA. Cell 95:177.187 Wang V, Mang W, Cao J, McElroy D, Wu R (1992) - 58 Characterization of cis. acting elements regulating transcription from dhe promoter of a constitutively active rice actin gene. Mol Cell Biol 12J399-3406 5 Williams S, Friedrich L, Dincher S, Carozzi N, Kessrnann H, Ward E, Ryals J (1992) Chemical regulation of Racillus thuringiensis delta-endmoxin expression in transgenic plants. BiotTech 10: 540-543, 10 W11mink A, van de Yen BC, Dons J3 (1995) Activity of constitutive promoters in vaxious species from the. Liliaceat Plant Mol Biol 28. 949-955 Zhang W, McElroy D, Wu R (1991) Analysis of doe AcrI 15 Yregion activity in transgcnic rice plants. Plant Cell 3:1155-1165
Claims (9)
1. A method of refining sugarcane to extract a transgenic peptide or peptide or protein comprising 5 the steps of: a. providing a sugarcane feedstock containing said transgenic protein; b. extracting said sugarcane feedstock to produce cane juice; 10 C. increasing the pH of the juice up to no more than pH7; d. cleaning said juice to remove particulate matter; and e. transmitting said juice through at least one 15 membrane in order to produce two fractions, one of said fractions containing said transgenic peptide or protein of interest.
2. A method of refining sugarcane to extract a 20 transgenic protein comprising the steps of: a. producing said transgenic protein in a transformed sugarcane plant; b. extracting juice containing said transgenic protein from stalks of said transgenic sugarcane 25 plant; c. increasing the pH of the juice up to no more than pH7; d. cleaning said juice to remove particulate matter; and 30 e. transmitting said juice through at least one membrane in order to produce two fractions, one of said fractions containing said transgenic protein of interest. 35
3. A method of producing a transgenic peptide or protein comprising the steps of: a. producing a transgenic sugarcane plant 3458658_1 (GHManers) P75112.AU.2 22/06/12 - 60 transformed with a gene coding for said peptide or protein; b. harvesting cane stalks from said transgenic sugarcane plant; s c. extracting sugarcane juice; d. increasing the pH of the juice up to no more than pH7; e. cleaning said juice to remove particulate matter; and 10 f. transmitting said juice through at least one membrane in order to produce two fractions, one of said fractions containing said transgenic peptide or protein. 15
4. A method according to any one of claims 1 to 3, wherein said transgenic protein is selected from the group consisting of a lectin, an enzyme, a vaccine, a bacterial lytic peptide, a bacterial lytic protein, an antimicrobial peptide, an antimicrobial protein, 20 an antiviral peptide, an antiviral protein, an insecticidal peptide, an insecticidal protein, a therapeutic peptide and a therapeutic protein.
5. A method according claim 1 or 2, wherein said 25 cleaning involves passing said juice through at least one screen.
6. A method according to claim 3, wherein said sugarcane juice after step (c) is passed through at least one 30 screen.
7. A method according to claim 5 or 6, wherein said screen removes particulates larger than about 100 to 150 microns in size. 35
8. A method according to any one of claims 1 to 3, wherein said membrane removes particulates larger 3458658_1 (GHMatters) P75112.AU.2 22/06/12 - 61 than about 0.05 to 0.2 microns.
9. A method according to any one of claims 1 to 3, wherein said membrane removes particulates larger 5 than about 150 kDa molecular weight. 3458658_I (GHMatters) P75112 AU.2 22/06/12
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008212072A AU2008212072B2 (en) | 2000-04-11 | 2008-09-09 | Regulatory element from a sugarcane proline rich protein and uses thereof |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60196085 | 2000-04-11 | ||
| AU2007201884A AU2007201884B2 (en) | 2000-04-11 | 2007-04-27 | Regulatory element from a sugarcane proline rich protein and uses thereof |
| AU2008212072A AU2008212072B2 (en) | 2000-04-11 | 2008-09-09 | Regulatory element from a sugarcane proline rich protein and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007201884A Division AU2007201884B2 (en) | 2000-04-11 | 2007-04-27 | Regulatory element from a sugarcane proline rich protein and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008212072A1 AU2008212072A1 (en) | 2008-10-09 |
| AU2008212072B2 true AU2008212072B2 (en) | 2012-07-12 |
Family
ID=38157610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008212072A Ceased AU2008212072B2 (en) | 2000-04-11 | 2008-09-09 | Regulatory element from a sugarcane proline rich protein and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2008212072B2 (en) |
-
2008
- 2008-09-09 AU AU2008212072A patent/AU2008212072B2/en not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| LEGAZ, M. E. et al., Plant Physiology, 1990, 92, 679-683. * |
| LEGAZ, M.E. et al. Analytica Chimica Acta. 1998, 372, 201-208. * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008212072A1 (en) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007201884B2 (en) | Regulatory element from a sugarcane proline rich protein and uses thereof | |
| DE60017781T2 (en) | MODULATION OF THE RESPONSE OF A PLANT ON ABSCISIN ACID | |
| AU2008264202B2 (en) | Enhanced silk exsertion under stress | |
| US10450580B2 (en) | Transcriptional regulation for improved plant productivity | |
| US20070271628A1 (en) | Wuschel (WUS) Gene Homologs | |
| US20040166563A1 (en) | Wuschel (WUS) gene homologs | |
| AU2003228935A1 (en) | Maize clavata3-like polynucleotide sequences and methods of use | |
| CA2985273A1 (en) | Late blight resistance genes and methods | |
| CN101218347B (en) | Plants having increased yield and a method for making the same | |
| JP2002525033A (en) | Pi-ta gene that confers disease resistance to plants | |
| CA2770872A1 (en) | Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake | |
| AU744673B2 (en) | Gene associated with disease resistance in plants | |
| KR101985653B1 (en) | Manufacturing method of optimized promoters inducible by phytohormone abscisic acid and uses thereof | |
| AU2008212072B2 (en) | Regulatory element from a sugarcane proline rich protein and uses thereof | |
| CN105175522B (en) | Crowtoe AP2/ERF transcription factors and its encoding gene and application | |
| EP1078086A2 (en) | Plant-derived resistance gene | |
| CN102549009A (en) | Functional expression of shuffled yeast nitrate transporter (YNT1) in maize to improve nitrate uptake under low nitrate environment | |
| CN114539373A (en) | IbPIF1 related to sweet potato stem nematode resistance as well as encoding gene and application thereof | |
| US6686513B1 (en) | Sugarcane ubi9 gene promoter sequence and methods of use thereof | |
| WO2000008189A2 (en) | Plant resistance gene | |
| US8901372B2 (en) | Plant resistance to banana bunchy top virus | |
| CA2324520A1 (en) | Plant promoter sequences and methods of use thereof | |
| CA2572305A1 (en) | Cell number polynucleotides and polypeptides and methods of use thereof | |
| AU771177B2 (en) | A novel maize RAD51-like gene and uses thereof | |
| Garapati | Identification of Differentially Expressed Genes in Water Stressed Roots through Suppression Subtractive Hybridization and Engineering DREB2 Homologue for Drought Tolerance in Sorghum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |